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ABSTRACT 
 
 
Synthesis of Nucleoside Analogues and Fluorescent Labels 
 for DNA Sequencing and Other Applications 
 in Biotechnology.  (August 2005) 
Mihaela Narcisa Predescu, B. S., University of Bucharest 
Chair of Advisory Committee: Dr. Emile Schweikert 
 
 
Two pyrrolo[2,3-d]pyrimidines and a nucleoside analogue have been prepared.  
The nucleobases were obtained by spontaneous cyclisation of 4-aminopyrimidyl-
acetaldehydes as an acetal.  The adenosine analogue has been made by glycosylation of a 
suitable sugar derivative with the corresponding heterocyclic base.  This nucleoside can 
be converted into fluorescently-labeled chain-terminating substrates for DNA 
polymerase after subsequent triphosphorylation and coupling to through-bond energy 
transfer systems. 
Fluorescein-based donor components to be incorporated into through-bond 
energy transfer systems have been prepared.  The synthesis of 5-ethynylfluorescein-(5-
tert-butoxycarbonyl)-pentyl ester has been executed in five steps from 1,3-
dihydroxybenzene and phthalic anhydride.  The donor fluorescein carboxylate has been 
alkylated with the tert-butyl ester of 6-bromohexanoic acid to provide a handle for 
attachment to biomolecules.  In the context of regioisomerically pure halofluoresceins, 
besides the synthesis of pure regioisomers of bromofluorescein derivatives, 5-
iodosulfofluorescein and pure regioisomers of 5-nitrofluorescein diacetate, as an 
intermediate in the synthesis of 5-iodofluoresceins, have been synthesized.   
New rhodamine-based acceptor components with extended aromatic systems 
have been prepared from an affordable starting material, tetralin.  The attempts to isolate 
them via repeated recrystallizations and flash chromatography have been unsuccessful.  
However, these pyrylium cations are expected to fluoresce at longer wavelengths. 
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CHAPTER I 
INTRODUCTION 
 
1.1 DNA Sequencing 
DNA sequencing is one of the fundamental techniques of modern molecular 
biology and it enables us to identify the sequence of nucleotides of the human genome.  
Two methods to sequence DNA were developed: the Maxam-Gilbert chemical 
degradation method, that describes a process whereby terminally labeled DNA 
molecules are chemically cleaved at single base repetitions,1 and the chain-terminator 
method of Sanger that involves the chain termination of DNA synthesis by the 
incorporation of 2′,3′-dideoxynucleoside triphosphates which act as chain-terminating 
inhibitors of the DNA polymerase.2   
Sanger dideoxy DNA sequencing is the most commonly used method for 
determining the nucleotide sequence of a DNA fragment.  It is based on the use of 
dideoxynucleotides in addition to the normal nucleotides found in DNA and it takes 
advantage of the chain terminating ability of dideoxynucleoside triphosphates and the 
ability of DNA polymerases to incorporate them almost as well as the natural substrate 
of DNA polymerase, deoxynucleoside triphosphates.   
In the chain-terminator technique (Figure 1.1), the oligonucleotide being 
sequenced is replicated by the enzyme using a suitable primer and the four 2′-
deoxynucleoside triphosphates.  In addition, the 2′,3′–dideoxynucleoside triphosphate of 
one of the bases is added to the reaction mixture and the reactions are performed in four 
different tubes.  As the DNA is synthesized, nucleotides are added in the growing chain 
by the DNA polymerase.  However, when a dideoxynucleotide is incorporated into the 
chain in place of a normal nucleotide, the chain is terminated by only one of the four  
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dideoxynucleoside triphosphates as dictated by the template DNA because of the 
absence of the hydroxyl group on the 3′-carbon.  A series of truncated fragments are 
produced.  They have different lengths due to the random incorporation of the 
dideoxynucleotides.  The fragments produced by all four dideoxynucleotides (in separate 
reactions) are then separated by electrophoresis according to their size in four separate 
lanes of a slab gel.  Each band differs in size and mobility by one nucleotide and the 
terminating nucleotide is identified by knowing which lane contains the band.  In this 
way, visualization of the bands permits deduction of the sequence of the DNA template.   
 
T e m p l a t e : 3'-CCGGTAGCAACT-5'
P r i m e r : 5'-GG-3'
d ATP
d CTP + ddCTP
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Figure 1.1.  A flow diagram of the chain-terminator method of DNA sequencing.3 
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The fragments are visualized using radioisotope or fluorescence labeled reagents. 
Radioisotopic labeling was originally used to visualize the oligonucleotide fragments.  
However, fluorescence detection has replaced radioisotopic detection4 because of the 
advantages that fluorescence-detection has.  Fluorescence labeling permits real-time 
detection and is more amenable to automated data collection and analysis.  In addition, 
the radioisotopes are unstable, expensive, and their handling and storing may be 
hazardous and difficult.  
With the latest advancement in technology, automated sequencing has been 
developed, and it is based on the same principles of Sanger’s method.  With the 
automated procedures more DNA can be sequenced in a shorter period of time and the 
reactions are performed in a single tube containing all four dideoxynucleotides, each 
labeled with a different color fluorescent dye. 
As in Sanger’s method, the DNA is separated by capillary electrophoresis, but 
they are all run on the same lane, not on four different ones.  Since the four dyes 
fluoresce at different wavelengths when irradiated with an appropriate laser source, the 
identity of each nucleotide can be determined according to the wavelengths at which the 
fluorescent dyes emit.  
  
1.2 Chain Terminators in DNA Sequencing 
 There are two variations of automated fluorescence-detected DNA sequencing: 
dye-labeled primer sequencing4-7 in which the fluorescent dyes are attached to the 5′-end 
of the primer oligonucleotide, and the dye-labeled terminator sequencing in which the 
fluorescent dyes are attached to the terminating dideoxynucleoside triphosphates.8  The 
dye-labeled terminator sequencing has several advantages over dye-labeled primer 
technique.  The major drawback of the dye-labeled primer sequencing is the requirement 
for four separate extension reactions.  In addition, four fluorescently-labeled primers 
need to be prepared for each template and fragments resulting from misincorporation of 
deoxynucleotides are visible to the detector.  The primary advantage of the dye-labeled 
terminator method is that only one extension reaction is required for each template.  
 4
Moreover, the DNA fragments that are terminated by a deoxynucleotide in place of a 
dideoxynucleoside (i.e. false terminations) are not fluorescent since these products are 
not fluorescently-labeled.  The dye-labeled terminator sequencing has disadvantages as 
well, the primary one being the limitation of the polymerase enzymes that can be used 
since these modified dideoxynucleotides are not accepted by many polymerases.  
However, many attempts towards elaborating enzymes that will satisfactorily integrate 
dye-terminators and that will be less discriminating against dideoxynucleotides have 
been made.9-11  The dye-labeled terminator technique uses 2′,3′-dideoxynucleoside 
triphosphates (Figure 1.2) which act as chain-terminating inhibitors of the DNA 
polymerase.  They are modified nucleotides that can be incorporated on the 3′-end of a 
template DNA, but once incorporated, prevent the addition of further nucleotides. This 
occurs because a phosphodiester bond cannot form between the dideoxynucleotide and 
the next incoming nucleotide since the dideoxynucleotide lack the hydroxyl group on the 
3′-carbon, and thus the DNA chain is terminated.   
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Figure 1.2.  2′,3′-Dideoxynucleoside triphosphates. 
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Prober et al. at DuPont developed the first set of dye-terminators for DNA 
sequencing.  They are comprised of a succinylfluorescein coupled to a 
dideoxynucleoside triphosphate via an acetylenic linker.  Their chemical structures along 
with their absorption and emission maxima are shown in Figure 1.3.   
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Figure 1.3.  The first dye-terminators.8 
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These chain-terminators were prepared from succinic anhydride and a suitably 
substituted resorcinol and were incorporated by both Avian myeloblastosis virus reverse 
transcriptase and T7 DNA polymerase.8  Since their discovery until today, the design of 
most of the dye-terminators is based on Prober’s terminators - the fluorescent dyes are 
attached to the 5-position of pyrimidine and the 7-position of 7-deazapurine 
dideoxynucleosides via a propargylamide linker.  The total synthesis of a nucleoside 
analogue, 7-iodo-2′,3′-dideoxy-7-deazaadenosine, is described in detail in Chapter II of 
this thesis.  Labeling these terminators with fluorescent dyes is quite important with 
respect to enzymatic incorporation, which makes the dye terminators to be quite 
expensive.    
 
1.3 Fluorescent Dyes in DNA Sequencing 
The fluorescent dyes that are attached to the 2′,3′-dideoxynucleoside 
triphosphates are critical to the sensitivity of DNA sequencing.  The major criteria which 
are used in the selection of these fluorophores are as follows: (1) their absorption and 
emission maxima have to be in the visible region of the spectrum; (2) the four dyes must 
emit at wavelengths that are different enough to allow them to be distinguished 
spectroscopically, when irradiated by an excitation source that emits at a single 
wavelength; (3) the presence of the fluorophores should not affect the electrophoretic 
mobility of the DNA fragments.  The ideal dyes should be highly fluorescent and should 
emit with similar intensities and with great resolution.  The aim of this thesis is not to 
describe all of the dye systems developed for DNA sequencing, but the most significant 
ones. 
The initial set of fluorescent dyes used in the original dye-primers was developed 
by Lloyd Smith and coworkers, who initiated the use of fluorescence detection in DNA 
sequencing in 1986.  The structures of these dyes, 5-carboxyfluorescein, 7-nitrobenzo-2-
oxa-1-diazole (NBD), tetramethylrhodamine, and Texas Red and their emission maxima 
are shown in Figure 1.4.  
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The emission maxima of these four dyes, which range from 520 nm to 595 nm, are in the 
visible region of the spectrum and are dispersed over a 75 nm wavelength range, which 
allow them to be differentiated spectroscopically.  
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Figure 1.4.  Dyes used in the original dye-primers.4 
 
However, there are problems with original dyes.  Their emission spectra overlap 
and not all dyes can be efficiently excited by a laser source that operates at a single 
wavelength. In addition, attachment of the dyes disturbed the electrophoretic mobilities 
of the labeled oligonucleotides.  
Further research has been undertaken to find modified dyes with improved 
fluorescent characteristics.  The structures of a common set of fluorescent dyes used to 
label the primers for DNA sequencing are shown in Figure 1.5.   These fluorescent dye-
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primers bear a fluorescein-based donor (FAM) attached to the 5′-end and other 
fluorescein and rhodamine derivatives connected to a modified thymidine residue in the 
primer sequence as acceptors.  Since these primers use fluorescence energy transfer to 
improve the spectroscopic properties of the label, they are called energy-transfer 
primers. 
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Figure 1.5.  Dyes used in energy-transfer primers.6 
 
The emission spectra of these modified dyes are reasonably different, which 
would allow good spectral differentiation.  However, when the dyes are excited by a 
laser source that operates at a single wavelength of 488 nm (the excitation from an 
Argon-laser), they emit with unequal intensities because not all these four dyes absorb 
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efficiently when excited by the same excitation source.  The fluorescence intensities 
depend on the amount of light absorbed at the excitation wavelength.  
 Metzker and Gibbs replaced the standard set of fluorescein and rhodamine dyes 
with boron dipyrrylmethane (BODIPY) dyes (Figure 1.6). 
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Figure 1.6.  BODIPY dyes used in Metzker’s energy transfer primers.7 
 
These dyes are based on an atypical fluorophore which contains boron and were 
used to label DNA primers.  BODIPY dyes have several advantages over conventional 
fluorescein and rhodamine dyes.  Their emission spectra are narrower, thus increasing 
the accuracy of base calling.  In addition, the BODIPY-labeled primers overcome 
electrophoretic mobility problems experienced with the previous dyes utilized in 
sequencing techniques.   
Prober and coworkers have developed a DNA sequencing system where the 
dideoxynucleoside triphosphate terminators (Figure 1.3) have been labeled with four 
different succinylfluorescein dyes.8  These single dye systems were spectrally resolved 
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and their attachment to the DNA fragments resulted in almost identical electrophoretic 
mobilities. 
Although single dyes systems offer the above advantages, not all four dyes can 
be effectively excited when irradiated by a laser source that emits at a single wavelength.  
Consequently, it is difficult to observe several fluorescently-tagged components at the 
same time because the dyes that emit at longer wavelengths absorb at the excitation 
wavelength less efficiently, and thus have decreased fluorescence intensities compared 
to the short wavelength fluorescent dyes.  The most commonly used DNA sequencers 
employ an argon laser and the dyes having longer wavelength emission do not have 
satisfactory absorbance at 488 or 514 nm.  A partial solution to overcome these 
drawbacks is using fluorescence resonance energy transfer (FRET) between two dyes, 
one dye-component as the donor that absorbs energy from the excitation source and the 
other dye-acceptor as the acceptor that fluoresces at a longer wavelength.  In the context 
of FRET systems, the excited-state energy from the initially excited donor is transferred, 
without emission of a photon, to an acceptor, resulting in emission of a longer 
wavelength photon from the acceptor.  The rate of energy transfer depends mainly on the 
extent of overlap between the emission spectrum of the donor and the absorption 
spectrum of the acceptor, the distance between the fluorophores (which is inversely 
proportional to the sixth power of the distance, r, between the donor and the acceptor), 
and their relative orientations.   
Mathies et al. have applied the energy transfer concept to four-color fluorescence 
detected sequencing to show that the energy transfer primers are better than single dye-
labeled primers.6  The donor component was attached to the 5′-terminus of the 
oligonucleotide primers.  The acceptor components were connected to the primary amine 
group on the modified base.  The donor dye chosen for Mathies’ experiment was 5-
carboxyfluorescein (FAM), and acceptor dyes selected were 2′,7′-dimethoxy-4',5'-
dichloro-6-carboxyfluorescein (JOE), N,N,N′,N′-tetramethyl-6-carboxyrhodamine 
(TAMRA), and 6-carboxy-X-rhodamine (ROX) (Figure 1.5).  These energy transfer 
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systems showed enhanced signal strengths compared to the single dye-labeled primers.  
However, they suffer from having disproportionate mobility shifts.   
In 1988, Lee and coworkers at Applied Biosystems                                                                             
analyzed a dye dimer named Bifluor-1 (Figure 1.7), synthesized and provided by 
Molecular Probes, Inc. 
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Figure 1.7.  Bifluor-1.12 
 
This compound is comprised of 4′-aminomethyl-5-carboxyfluorescein as a donor 
and 5-carboxytetramethylrhodamine as an acceptor connected via an 
aminomethylbenzoic acid linker.  Their analysis showed that the absorption spectrum of 
Bifluor-1 was the cumulative spectra of the two dye fragments.  Moreover, excitation of 
the dimer produced fluorescence characteristic of only the acceptor component, 
tetramethylrhodamine, meaning that the energy was efficiently transferred between the 
two dye components.  However, since Bifluor-1 proved to be no brighter than the 
tetramethylrhodamine portion alone, Lee’s effort was then directed towards improving 
its spectral properties by preparing diverse combinations of fluorescein and rhodamine 
components of the original Bifluor-1.  Consequently, a set of four dichlororhodamine 
dyes was prepared by adding 4, 7-dichlorosubstituents to the rhodamine dyes.  They 
have sharper emission profiles and emit at longer wavelengths than the unsubstituted 
rhodamines.  These energy transfer systems have been initially designed for use in dye-
primer sequencing.  The same year, they extended the advantages of the energy transfer 
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to dye-terminators and designed the “Big Dyes” (Figure 1.8).  These dye-terminators 
proved to be superior to previous dye-terminators with respect to signal-to-noise ratios 
and even peak patterns.   
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Figure 1.8.  Structure of the ddT-Big Dye terminator.5 
 
However, the Big Dyes have a drawback - they are all chiral and show 
atropisomerism.  When they are attached to the dideoxynucleotides, a mixture of 
diastereoisomers having non-identical electrophoretic mobilities forms.  To alleviate this 
problem, Lee et al.13 prepared dyes optically pure by coupling the corresponding 
fluorescein derivative with (-) menthyl chloroformate to yield two diastereoisomers 
which were separated by HPLC. 
Although the fluorescence resonance energy transfer systems proved to be a 
significant improvement over the single dye systems, unfortunately, the resolution of 
emissions with FRET-based systems is still limited by the requirement that the 
fluorescence of the donor must overlap with the absorption of the acceptor.  To alleviate 
this problem, Lindsey and coworkers developed through-bond energy transfer dyes 
wherein two fluorescent dyes, a donor and an acceptor, are connected via a conjugated 
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system.14,15   The through-bond pathway does not require overlap between the emission 
spectrum of the donor and the absorption spectrum of the acceptor as opposed to the 
Förster mechanism.  Moreover, the rate of energy transfer involving conjugated linkers 
is not as constrained by the distance between the two fluorophores.  Optimal through-
bond energy transfer systems should contain a donor component that absorbs strongly 
when excited by a convenient excitation source, and an acceptor component that 
fluoresces strongly once the energy is transferred efficiently from the donor fragment via 
the conjugated linker.  Selection of the linker is also critical.  The linker does not have to 
allow the donor and acceptor components to become planar, otherwise each dye 
fragment would not retain its individual electronic properties and the system would 
behave as a single conjugated dye.  However, a large deviation from planarity must be 
avoided in order for energy transfer to occur.  Through-bond energy transfer systems 
have the ability to enhance both the resolution and fluorescence intensities when excited 
by a laser source that emits at a single wavelength. 
A representative example of through-bond energy transfer systems that Lindsey 
developed is the one that employs a BODIPY dye as a donor component and a free base 
porphyrin as an acceptor, conjugated via metalloporphyrin linker (Figure 1.9).  The 
efficiency of energy transfer of 76 % measured when exciting the BODIPY donor is 
superior to that expected from fluorescence resonance energy transfer (6 %).   
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Figure 1.9.  Lindsey’s “molecular wire”.14  
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Figure 1.10.  Through-bond energy transfer cassettes.16 
 
A set of four through-bond conjugated cassettes useful for multiplexing has been 
developed by Jiao et al.  All four systems employ fluorescein as a donor conjugated to 
rhodamines or extended rhodamines (Figure 1.10).  The fluorescence spectrum of these 
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cassettes shows that their emission maxima are spread over a 78 nm wavelength range, 
which reflects a good resolution.  As for the sensitivity, they fluoresce more brightly 
than the corresponding acceptor components when irradiated at 488 nm.  The 
experiments to measure the rates of energy transfer are underway. However, these 
through-bond energy transfer systems might substitute for many fluorescent dyes used 
currently for DNA sequencing. 
 
1.4 Summary 
 DNA sequencing is one of the fundamental techniques of modern molecular 
biology and it enables us to identify the sequence of nucleotides of the human genome.  
Of the two methods used for DNA sequence analysis, Sanger dideoxy DNA sequencing 
is the most commonly used.  It is based on the use of dideoxynucleotides in addition to 
the normal nucleotides found in DNA and it takes advantage of the chain terminating 
ability of dideoxynucleosides triphosphates and the ability of DNA polymerase to 
incorporate them almost as well as the natural substrate of DNA polymerase, 
deoxynucleoside triphosphates.  Fluorescence detection has replaced radioisotopic 
detection because it permits real-time detection and is more susceptible to automated 
data collection and analysis.  In addition, the radioisotopes are unstable, expensive, and 
their handling and storing may be hazardous and difficult.  
The fluorescent dyes that are attached to the 2′,3′-dideoxynucleoside 
triphosphates are critical to the sensitivity of DNA sequencing.  The ideal fluorophores 
should comply with the following requirements: (1) their absorption and emission 
maxima have to be in the visible region of the spectrum; (2) the four dyes must emit at 
wavelengths that are different enough to allow them to be distinguished 
spectroscopically when irradiated by an excitation source that emits at a single 
wavelength; (3) the presence of the fluorophores should not affect the electrophoretic 
mobility of the DNA fragments.  The ideal dyes should be highly fluorescent and should 
emit with similar intensities and with great resolution.  Developments in fluorescent dyes 
showed that the through-bond energy transfer systems are superior to the single dyes and 
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FRET-based systems since they have the ability to enhance both the resolution and 
fluorescence intensities when excited by a laser source that emits at a single wavelength.  
Through-bond energy transfer systems have applications not only in DNA sequencing, 
but also other applications in biotechnology, if optimized to provide longer wavelength.  
One of the challenging applications is intracellular imaging which focuses on defining 
the role of the numerous proteins in the cellular processes associated with health and 
disease and can be facilitated by developments in fluorescent dyes and proteins.   
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CHAPTER II 
NUCLEOSIDE ANALOGUES 
 
2.1 Introduction 
Nucleosides and their analogues are of great importance in molecular biology.  
They can be used as therapeutic agents possessing antiviral and anticancer activity, in 
detection of nucleotide mutations, and in DNA sequencing.   
The most popular terminators of enzymatic DNA synthesis are 2′,3′-
dideoxynucleosides that are the core for currently used sequencing procedures.  Since 
the synthesis of the first pyrimidine 2′,3′-dideoxynucleoside, 3′-deoxythymidine, by 
Michelson and Todd17 in 1955, various 2′,3′-dideoxynucleoside analogues have been 
synthesized.  In 1964, Robins and Robins18 described the synthesis of the first purine 
dideoxynucleoside, 2′,3′-dideoxyadenosine, and anticipated that their 5′-triphosphates 
might act as potential chain-terminating inhibitors of the DNA polymerases 
dideoxynucleotide because they lack the hydroxyl group on the 3′-carbon.  That 
hypothesis was developed later on by Sanger into the well known dideoxy method of 
DNA sequencing.2
The continuing search for optimal DNA sequencing reagents is due to the variety 
of polymerases, nucleotide analogues, and reaction conditions available.  In general, the 
enzymes used for sequencing DNA are highly substrate selective.  DNA polymerases 
can be classified in three families: A, B, and C.  The most widely used enzymes in DNA 
sequencing are DNA polymerases of Family A (e.g. E. coli pol I, T7, Taq DNA 
polymerases).  One of the first set of dyes developed for T7 DNA polymerase contained 
a propargylamino linker connected to fluorescein dyes.  However, the dye terminators 
developed for Taq Pol I contained rhodamines, since fluorescein terminators were poorly 
incorporated.9  DNA polymerases of other families have also been examined for their 
ability to incorporate modified nucleotides.  Family B Archaeon incorporate acyclic 
nucleoside triphosphates preferentially over dideoxy terminators, while the Family A 
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DNA polymerases Taq have a preference for dideoxy terminators.  An explanation for 
this preference is that there are considerable differences in sugar recognition in these two 
families of polymerases.11  AcycloTerminators consist of an acyclic nucleoside 
triphosphate looking like the herpes drug Acyclovir, an acyclic analogue of guanosine, 
9-[(2-hydroxyethoxy)methyl]guanine (Figure 2.1) attached to near-IR cyanine dyes.  
AcycloTerminators have the advantage that their synthesis is less laborious and 
affordable compared to the sugar-based dideoxynucleotides. 
 
NH
NN
N
O
NH2
O
OH
 
Figure 2.1.  Acyclovir 
 
The significant differences in enzymatic incorporation of the terminators noted in 
the examples mentioned above lead to the conclusion that it is difficult to predict 
structural or chemical basis by which terminators enhance enzymatic incorporation.  
However, there are two fundamental structure characteristics that the nucleoside 
analogues must maintain.  When modifying the base, it is important to consider its 
ability to form hydrogen bonds with its complementary DNA base.  On the other hand, 
when modifying the sugar component, the only requirement is the 5′-hydroxyl group 
which is engaged in phosphorylation.  Consequently, there is more flexibility to vary the 
sugar moiety.   
Attempts to find optimal nucleoside analogues with respect to both less laborious 
synthesis and ability to be enzymatically incorporated have been made.  Thus Martinez 
et al.  developed some acyclic nucleoside analogues and evaluated them as substrates for 
DNA polymerases (Figure 2.2).  Although their synthesis is not laborious, the 
corresponding triphosphates were incorporated by the enzymes employed less efficiently 
than dideoxythymidine and dideoxyadenosine triphosphates. 
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Figure 2.2.  Acyclic nucleoside analogues.19 
 
Other nucleoside analogues containing a blocking group at the 3′-hydroxyl group 
have been synthesized and evaluated for other approaches to DNA sequence analysis.  
These 2′-deoxynucleoside triphosphates looked like the dideoxynucleoside triphosphates 
with regard to the ability to terminate the DNA chain.  Metzker et al. synthesized several 
3′-o-nitrobenzyl nucleoside triphosphates (Figure 2.3) and tested them as substrates for 
several DNA replication enzymes.  The results showed that the enzymes employed in the 
experiments efficiently incorporated the 3′-analogues.  However, incorporation did not 
occur for any of the enzymes tested when a large fluorescent label was attached to the 
same position.   
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       2′-deoxy-3′-O-methylthymidine                  2′-deoxy-3′-O-(2-nitrobenzyl)adenosine 
 
Figure 2.3.  Metzker’s 3′-blocked triphosphates.20 
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A few years later, other nucleoside triphosphates with both fluorescent and 
photolabile 3′-O-blocking groups were prepared and tested for incorporation.21  The 
analogues were not incorporated by the enzymes employed, being too large to fit into the 
active site of the enzymes.   
Although efforts have been made towards the synthesis of alternative nucleoside 
analogues to be converted into chain-terminators of the DNA polymerase, 2′,3′- 
dideoxyribonucleoside-5′-triphosphates  are the most popular.  Several positions are 
theoretically available for attachment of the fluorophores and for this reason, the position 
for modification of purines was uncertain.  However, the position of substitution of the 
four bases is critical since it has an intense effect on polymerase activity.  The instability 
and toxicity problems associated with the common 2′,3′-dideoxynucleosides were 
overcome by replacing the ordinary purine moiety by a 7-deazapurine base.  While the 
8-position of the purines is easily brominated, 8-substituted purine nucleosides show a 
preference for the syn-conformation at the N-glycosylic bond that does not make them 
appropriate for DNA polymerases.9, 22  Moreover, alkylation at the 7-nitrogen would 
produce an unstable nucleoside. 
2′,3′-Dideoxynucleosides are typically synthesized by multistep transformations 
from intact nucleosides,23-26 involving deoxygenation reactions to 2′,3′-unsaturated 
dideoxynucleosides, which are then hydrogenated, or from 2′-deoxynucleosides via 
Barton-type deoxygenation reactions.26-28  7-Iodo-2′,3′-dideoxy-7-deazaadenosine can be 
synthesized by deoxygenation of the naturally occurring tubercidin, followed by 
regioselective mercuration/iodination as outlined in Figure 2.4. 
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Figure 2.4.  Synthesis of 7-iodo-2′,3′-dideoxy-7-deazaadenosine from tubercidin.24,25 
 
However, there are alternative pathways to 7-iodo-2′,3′-dideoxy-7-
deazaadenosine that do not employ tubercidin, an expensive fermentation product, but 
involve deoxygenation reactions of 2′-deoxynucleosides.  This route is described in great 
detail in this chapter. 
 
2.2 Total synthesis of 7-iodo-2′,3′-dideoxy-7-deazaadenosine    
In a total synthesis of 7-iodo-2′,3′-dideoxy-7-deazaadenosine that was executed 
in 13 steps following Cocuzza’s procedure,28 4-chloro-7H-pyrrolo[2,3-d] pyrimidine and 
2-deoxy-3,5-ditoluoyl pentafuranosyl chloride were used as starting materials.  However, 
owing to their unaffordable cost, they were synthesized from less expensive 
commercially available starting materials.   
4-Chloro-7H-pyrrolo[2,3-d] pyrimidine was synthesized from cheap starting 
materials29,30 (Scheme 2.1).  Thus, the reaction of bromoacetal 1 with ethyl cyanoacetate 
(2) afforded ethyl diethoxyethylcyanoacetate 3 in 30 % yield after purification by 
vacuum distillation.  Condensation of the mononitrile 3 with an ethanolic solution of 
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thiourea and sodium ethoxide furnished in 80 % yield the mercapto-pyrimidine 4 that 
was then subjected to a desulphurization reaction using Raney nickel to afford the 
corresponding pyrimidine 5 in 90 % yield.  The pyrrolo-pyrimidone 6 was obtained in 65 
% yield by spontaneous cyclisation of the acetal 5 when treated with hydrochloric acid at 
room temperature.  Treatment of 4-hydroxypyrrolo pyrimidine 6 with phosphoryl 
chloride afforded the pure 4-chloro-7H-pyrrolo[2,3-d]pyrimidine (7) in 40 % yield after 
recrystallisation from ethyl acetate.    
 
Scheme 2.1.  Synthesis of 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine 
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 The sugar moiety, 2-deoxy-3,5-ditoluoyl pentafuranosyl chloride, 11, has been 
synthesized from the accessible, commercially available 2-deoxy-ribose 8 according to a 
literature procedure (Scheme 2.2).31,32  Thus, the 2-deoxy-ribose 8 was converted to the 
anomeric mixture of methyl pentofuranosides 9 using methanolic hydrogen chloride 
generated in situ by adding acetyl chloride to methanol.  After the methanol was 
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removed completely, the mixture was acylated by treatment with p-toluoyl chloride in 
pyridine to furnish a crude mixture of bis(4-methyl benzoates) 10, which was purified by 
flash chromatography to give the α-isomer in 63 % yield.  The α-methoxy derivative 10 
was converted to the corresponding α-chloride by adding a saturated solution of 
hydrochloric acid in acetic acid prepared according to the same procedure used in the 
first step.  The chloride precipitated immediately and afforded the α-chloride derivative 
in 57 % yield.  This compound is stable in the solid state and decomposes when exposed 
to atmospheric humidity. 
 
Scheme 2.2.  Synthesis of 2-Deoxy-3,5-ditoluoyl pentafuranosyl Chloride 
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 With the sugar and base parts in hand, we proceeded with the synthesis of the 
nucleoside, which was executed in 7 steps (Scheme 2.3).26,28  Alkylation of the sodium 
salt of the deazapurine 7, produced in situ by sodium hydride in acetonitrile, with 1-
chloro-2-deoxy-3,5-ditoluoyl pentafuranose 11 afforded β-deoxiribonucleoside 12 in 71 
% yield.  Complete removal of the toluoyl groups was accomplished by extended 
treatment of the protected nucleoside with methanolic ammonia to furnish the diol 13 in 
70 % yield.  Regioselective protection of 5′-hydroxyl group with pivaloyl chloride gave 
the pivaloyl derivative 14 in 50 % yield.  Compound 14 was then acylated with phenyl 
chlorothionocarbonate affording 15 in 90 % yield.   
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Scheme 2.3.  Synthesis of 7-Iodo-2′,3′-dideoxy-7-deazaadenosine 
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Subsequent treatment of the latter with tributyltin hydride employed in Barton 
deoxygenation gave the corresponding dideoxynucleoside 16 in 64 % yield.  The 
pivaloyl derivative of the dideoxynucleoside was then treated with an electrophilic 
reagent, iodine monochloride, and 7-iodo-7-deazapurine derivative 17 was isolated as 
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the only regioisomer in 90 % yield.  Treatment of the latter with methanolic ammonia at 
120 oC resulted in removing the pivaloyl protecting group with concomitant nucleophilic 
displacement of the 4-chloro group affording the target compound, 7-iodo-2′,3′-dideoxy-
7-deazaadenosine, 18, in 90 % yield.  This compound was further used for converting 
into fluorescence-labeled chain terminating substrates for DNA polymerase.   
   
Scheme 2.4.  Synthesis of 4-Methoxy-2-methylsulfanyl-7H-pyrrolo 
[2,3-d]pyrimidine 
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In addition to 7-iodo-2′,3′-dideoxy-7-deazaadenosine, we also synthesized a  
common intermediate for the preparation of 7-iodo-2′,3′-dideoxy-7-deazaguanosine, 4-
methoxy-2-methylsulfanyl-7H-pyrrolo[2,3-d]pyrimidine.  It contains a bulky substituent 
at C-2 and its methoxy group avoids keto-enol tautomerism at N-1/O-6.  These 
precautions diminish the electrophilic attack of N-2 and N-6 during glycosylation. 
4-Methoxy-2-methylsulfanyl-7H-pyrrolo[2,3-d]pyrimidine (22) was prepared 
from bromoacetal 1 and ethyl cyanoacetate (2) in  a manner similar to one described for 
synthesis of 4-chloro-7H-pyrrolo[2,3-d] pyrimidine (Scheme 2.4).29,30,33  The mercapto-
pyrimidine 4 was treated with dimethyl sulfate to afford 2-methylthiopyrimidine 19 in 
80 % yield.  Spontaneous cyclisation of the acetal 19, which proceeded in 70 % yield, 
was followed by treatment with phosphoryl chloride affording the 4-chloro-derivative 21 
in 40 % yield.  Substitution of the chloro-group by a methoxy group using a solution of 
sodium methoxide in methanol furnished 4-methoxy-2-methylsulfanyl-7H-pyrrolo[2,3-
d]pyrimidine (22) in 70 % yield.  This compound can be further used for preparation of 
another precious nucleoside analogue, 7-iodo-2′,3′-dideoxy-7-deazaguanosine. 
 
2.3 Conclusion 
 7-Iodo-2′,3′-dideoxy-7-deazaadenosine has been synthesized in 15 steps from 
affordable starting materials by a series of protection, deoxygenation, and iodination 
steps.  4-Methoxy-2-methylsulfanyl-7H-pyrrolo[2,3-d]pyrimidine, a common 
intermediate for the preparation of 7-iodo-2′,3′-dideoxy-7-deazaguanosine, has also been 
synthesized in 6 steps.  Triphosphorylation of the 7-iodo-2′,3′-dideoxy-7-
deazaadenosine, coupling the fluorescent dyes to the resulting nucleotide, its enzymatic 
incorporation into a growing DNA strand, and evaluation as chain-terminating inhibitors 
of the DNA polymerases are underway. 
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CHAPTER III 
FLUORESCEIN-BASED DONOR COMPONENTS                                  
 
3.1 Introduction 
 Fluorescein is one of the most common dyes used for fluorescence detection.  It 
has a large fluorescence quantum yield (0.92 at pH > 8), good water solubility, a 
favorable absorption spectrum, and it is commercially available in many derivatives.  In 
addition, fluorescein has an absorption maximum (494 nm) that closely matches the 488 
nm spectral line of the argon lasers employed by the two most widely used DNA 
sequencers, Applied Biosystems 3700 and 3730 DNA sequencers.   
 Owing to the advantages that fluorescein possesses, fluorescein derivatives are 
widely used as fluorescent detection reagents in many biochemical experiments to label 
macromolecules, and for this reason, over the years, a variety of functionalized 
fluoresceins have been prepared.  However, in spite of their widespread use in 
biotechnology, fluorescein-based components and their conjugates have well-known 
deficiencies.  Fluorescein conjugates are unstable - they photobleach too easily, resulting 
in a fast decrease in fluorescent signal.34  Other drawbacks are that the absorption and 
fluorescence properties of fluorescein are pH dependent and fluorescein-based dyes have 
a tendency toward quenching of their fluorescence when conjugating to biomolecules.  
In those biochemical experiments where sensitivity is critical (e.g. when preparing 
conjugates of the dyes to proteins), the fluorescein-based donors are replaced by 
different donors (e.g. rhodamines, fluorinated fluoresceins34). 
 The synthesis of fluorescein was first reported in 1871 by Von Bayer.35  It was 
easily prepared by the condensation of resorcinol with phthalic anhydride in the presence 
of zinc chloride as a catalyst.  However, preparation of fluorescein derivatives using 
similar methods with substituted phthalic anhydrides is difficult because the reaction 
gives mixtures of regioisomers and isolation of the pure products proved to be a serious 
problem.  Halogenated fluoresceins are useful substrates in Suzuki and Sonogashira 
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coupling reactions.  The Sonogashira coupling36 is widely used in the synthesis of 
fluorescent donor-acceptor dyes.  Coupling of aryl halides with a monosubstituted 
alkyne to obtain a 1,2-disubstituted acetylene is accomplished by palladium(0) and a co-
catalyst, copper iodide.   
Methodologies for preparation of pure regioisomers of halogenated fluoresceins 
have been developed and the derivatives mentioned below are just a few examples that 
illustrate this.  It is necessary to prepare isomerically pure fluoresceins because multistep 
preparation of fluorescein derivatives requires pure regioisomers in order to purify and 
identify easily the reaction products.  On the other hand, when mixtures of 5- and 6-
isomers are conjugated to biomolecules, there are differences in conjugate polarity and 
internal fluorescence quenching.37  Thus, 2′,4′,5′,7′-tetrabromofluorescein (eosin 1), 
2′,4′,5′,7′-tetra-iodofluorescein (erythrosine 2), and 2′,4′,5′,7′- tetra-bromo-4,5,6,7-tetra-
chlorofluorescein (rose bengal 3) shown in Figure 3.1 were prepared right after 
fluorescein was originally synthesized, but they suffer from much lower fluorescence 
quantum yields compared with fluorescein.  Fluorescein, which is unsubstituted, has a 
high fluorescence quantum yield, while Eosin, Erythrosin, and Rose Bengal intersystem-
cross to the triplet state and have a higher population of triplet relative to singlet, 
fluorescing with lower quantum efficiency.38  Heavy atoms substitution in an aromatic 
molecule usually increases singlet-triplet transitions owing to increased spin-orbit 
mixing of the singlet and triplet manifolds.  Substitution by heavy atoms may affect the 
vibrational state and change the fluorescence spectra, and the electronic excitation 
energy is converted into vibrational energy, the fluorescence becoming weak.39  For 
example, the four iodine atoms of Rose Bengal increase its intersystem-crossing yield 
relative to fluorescein, which means that Rose Bengal fluoresces red, but weakly.  On 
halogen substitution, a decrease in fluorescence quantum yield is observed in the 
sequence of Cl, Br, and I owing to the heavy atom effect.  Unlike these halogenated 
fluoresceins, which have expected properties resulting from the substitution effect, the 
substitution of hydrogen atoms by fluorine atoms produce intense changes in their 
properties, mainly owing to the highly electronegative nature and small Van der Waals 
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radius of the fluorine atom.  Regioisomerically pure fluorinated fluoresceins have been 
synthesized.  They proved to be superior to other fluorescein derivatives for 
bioconjugation owing to their high quantum yield, resistance to photobleaching, and 
decreased quenching when conjugating to biomolecules.34 
 
O O
CO2H
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Y
Y Y
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X X
X
1: X = Br, Y = H
2: X = I, Y = H
3: X = I, Y = Cl  
Figure 3.1.  Fluorescein derivatives.34 
 
Preparation routes to pure regioisomers of 5- or 6-halofluoresceins have been 
reported as well.  They are prepared by condensation of resorcinol with substituted 
phthalic anhydride and sulfocarboxy anhydride, respectively.40  They are valuable 
substrates for preparation of the fluorescein-based donor components (Figure 3.2) to be 
incorporated into through-bond energy transfer cassettes for DNA sequencing and other 
applications in biotechnology.16  Because they are important synthetic building blocks 
used to make various dyes, our efforts have been focused on making more fluorescein-
based donors via halogenated fluoresceins.  This chapter describes synthesis of pure 
halofluoresceins and a fluorescein-based donor component, 5-ethynylfluorescein-(5-tert-
butoxycarbonyl)-pentyl ester.   
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Figure 3.2.  Target compounds for Chapter III. 
 
3.2 Synthesis of 5-Ethynylfluorescein-(5-tert-butoxycarbonyl)-pentyl Ester 
 5-Ethynylfluorescein-(5-tert-butoxycarbonyl)-pentyl ester (29) is a fluorescein-
based donor fragment useful for incorporation into through-bond energy transfer dyes 
designed especially for DNA sequencing.  It contains two significant functionalities - 
one is used to attach the acceptor fragment, and the other one is used to add the linker for 
attachment to biomolecules.  The synthesis of 5-ethynylfluorescein-(5-tert-
butoxycarbonyl)-pentyl ester (29) was executed in 5 steps (Scheme 3.1) starting with 
accessible starting materials according to a procedure reported by Jiao et. al.40 and by 
Thoresen et. al.41    Thus, condensation of 1,3-dihydroxybenzene (23) with 4-bromo 
phthalic anhydride (24) yielded 5- and 6-bromofluoresceins 25a and 25b as a mixture of 
two regioisomers. The crude mixture of these two isomers was subjected to acylation 
reaction with acetic anhydride without further purification.  5-Bromofluorescein was 
isolated as the ring closed diacetate by fractional crystallization from acetic anhydride.  
The reaction yield in 5-bromofluorescein diacetate was 28 % and no chromatography 
was necessary.  The 6-isomer was also isolated as the ring-closed diacetate from the 
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mother liquor by repeated recrystallization from ethanol.  5-Bromofluorescein diacetate 
was subjected to Sonogashira reaction using trimethylsilyl acetylene in the presence of 
Pd(0) catalyst to afford 5-(2-trimethylsilylethynyl) fluorescein diacetate 27 in 75 % yield 
after recrystallization from ethanol.  Deprotection of 27 with potassium carbonate gave 
in 80 % yield 5-ethynyl fluorescein 28 that precipitates from the reaction conditions 
when acidified with concentrated HCl.  A linker for attachment to biomolecules was 
installed by alkylating the carboxylate of 5-ethynylfluorescein with the tert-butyl ester of 
6-bromohexanonoic acid to furnish in 60 % yield the target compound, 5-
ethynylfluorescein-(5-tert-butoxycarbonyl)-pentyl ester 29 used further for incorporation 
into through-bond energy transfer cassettes.  
 In the context of halogenated fluoresceins, in addition to bromofluoresceins, 
other valuable substrates used for preparation of fluorescein-based donors are 
iodofluoresceins.  They can be prepared via diazotization/iodination of the 
corresponding aminofluoresceins that are commercially available.  However, owing to 
their high cost, aminofluoresceins were synthesized from affordable starting materials 
via the same route as the one used for preparation of bromofluoresceins according to the 
literature procedure (Scheme 3.2).42,43  Thus, condensation of 1,3-dihydroxybenzene (23) 
with 4-nitrophthalic anhydride (30) gave a mixture of 5- and 6-nitrofluoresceins 31a and 
31b, which was further used for acylation to the ring-closed diacetate.  5-
Nitrofluorescein diacetate 32 was isolated, as the only isomer, via fractional 
crystallization from acetic anhydride in 30 % yield.  Further reduction of the nitro group, 
followed by diazotization and treatment with potassium iodide afford the corresponding 
iodofluorescein, an important intermediate for preparation of fluorescein-based donors to 
be incorporated into donor-acceptor cassettes. 
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Scheme 3.1.  Synthesis of 5-Ethynylfluorescein-(5-tert-butoxycarbonyl)-pentyl Ester 
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Scheme 3.2.  Synthesis of 5-Nitrofluorescein Diacetate 
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3.3 Synthesis of 5-Iodosulfofluorescein 
 Other useful halofluoresceins used in preparation of fluorescent donor-acceptor 
cassettes are sulfonic acid derivatives of 5-iodofluoresceins.  Compared to fluoresceins, 
the sulfonic acid derivatives enjoy greater water solubility as they contain the sulfonic 
acid group.  Moreover, only one isomer can form when using substituted 2-sulfobenzoic 
anhydrides as substrates for preparation of sulfofluoresceins since only one carbonyl 
group is available for condensation.  This is a significant advantage of sulfofluoresceins 
since the laborious separation of regioisomers is not necessary.  Described here are the 
preparation of sulfocarboxy anhydride and its condensation with 1,3-dihydroxybenzene 
to form sulfofluoresceins according to the literature procedure.44, 45  
 Synthesis of 5-iodo-2-sulfobenzoic anhydride was executed in 5 steps starting 
from accessible starting materials according to the literature procedures (Scheme 3.3).44-
46  Thus, oxidation of 2-methyl-5-nitrobenzenesulfonic acid (32) with potassium 
permanganate afforded 33 in 66 % yield.  The sodium salt 33 was then subjected to a 
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hydrogenation reaction with palladium catalyst to furnish the aminoderivative 35 in 80 
% yield.  Diazotization, followed by iodination of the corresponding aminoderivative 
afforded 36 in 65 % yield.  This was treated then with thionyl chloride to furnish 5-iodo-
2-sulfobenzoic anhydride 37 in 30 % yield.  Condensation of sulfocarboxy anhydride 37 
with 1,3-dihydroxybenzene (23) in the the presence of methanesulfonic acid which acts 
both as solvent and catalyst, yielded the target compound  38, a 5-iodosulfofluorescein 
derivative, in 90 % yield (Scheme 3.4).  The product precipitated from the reaction 
conditions when a limited quantity of water was added to the reaction mixture. 
 
Scheme 3.3  Synthesis of 5-Iodo-2-sulfobenzoic Anhydride 
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Scheme 3.4. Synthesis of 5-Iodosulfofluorescein Derivative 
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3.4 Conclusion 
 A fluorescein-based donor component, 5-ethynylfluorescein-(5-tert-
butoxycarbonyl)-pentyl ester, has been prepared in five steps starting with accessible 
starting materials, 1,3-dihydroxybenzene and 4-nitrophthalic anhydride, via 5-
bromofluorescein diacetate.    The pure regioiosmer of  bromofluorescein diacetate has 
been isolated by repeated fractional crystallization from acetic anhydride and can be 
prepared in gram quantities.   
 In the context of halofluoresceins, pure 5-nitrofluorecein diacetate has been 
prepared and isolated via the same route as the one described for bromofluorecein.  
Further reduction/diazotization/iodination reactions give the corresponding 
iodofluoresceins, important intermediates for preparation of fluorescein-based donors to 
be incorporated into donor-acceptor cassettes. 
 Preparation of sulfonic acid derivatives enjoys the advantage that only one 
isomer can form when using substituted 2-sulfobenzoic anhydrides since only one 
carbonyl group is available for condensation.  This way the laborious separation of 
regioisomers is not necessary.  Synthesis of 5-iodo-2-sulfobenzoic anhydride was 
executed in 5 steps starting from accessible starting materials. 
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 Fluorescein-based donor fragments are important synthetic building blocks to be 
incorporated into through-bond energy transfer cassettes for DNA sequencing and other 
applications in biotechnology. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 37
CHAPTER IV 
RHODAMINE-BASED ACCEPTOR COMPONENTS    
 
4.1 Introduction 
 Rhodamine dyes are important owing to their favorable photochemical and 
photophysical properties.  Thus, rhodamine dyes have many favorable fluorescence 
properties – they have relatively long absorption maxima, they have high quantum yields 
(0.45 to 0.95) and high molar extinction coefficients.  Compared to the fluorescein dyes, 
rhodamine dyes are relatively resistant to photobleaching and their fluorescence spectra 
are pH-independent over a wider pH range (from 4 to 10).47  Moreover, dye-terminators 
labeled with rhodamine dyes are more efficiently incorporated by DNA polymerase 
TaqFS.9 
Because of their high fluorescence quantum yield and photostability, rhodamine 
dyes have widespread applications, not only in biotechnology, e.g. fluorescent labeling, 
single molecule detection, etc., but also in medicine for staining damaged cells, etc. 
The ideal rhodamine-based acceptors for the energy transfer systems useful for 
cellular imaging should emit above 650 nm.  However, rhodamines have emission 
wavelengths shorter than ideal, so that rhodamines with extended and planar aromatic 
systems are of more interest.  The rhodamine dyes that emit at wavelengths above 650 
nm avoid background signals caused by biological autofluorescence. 
 Various rhodamine dyes have been prepared and used as fluorescent labeling 
reagents over the years.  5-Carboxyrhodamine 6G hydrochloride, lissamine rhodamine B 
sulfonyl chloride, Texas Red sulfonyl chloride, and tetramethylrhodamine isothiocyanate 
are among the most widely used fluorescent reagents.  Their structures are shown in 
Figure 4.1.  Texas Red derivatives, that contain julolidine rings, enjoy an increase in 
their fluorescence quantum yields relative to those of the rhodamine derivatives without 
extended aromatic systems.  This increase is due to the fact that these rings prevent 
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rotation about the nitrogen atoms and lead to a shift of their fluorescence spectra to 
longer wavelengths. 
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Figure 4.1.  Representative structures of rhodamine derivatives.48 
 
 Two other new classes of dyes that intensely fluoresce in the 600–700 nm range 
are shown in Figure 4.2.  Their strong fluorescence efficiency is due to the planarity and 
rigidity of the major part of the systems.  The first class, the amide-bridged 
benzopyrylium dyes, are related to rhodamines, while the second class, carbopyronin 
dyes, are derived from rhodamines by replacing the O-atom by a carbon atom, for both 
classes their absorption and emission spectra are shifted to longer wavelengths.  These 
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types of dyes might be varied in many ways to obtain halogenated acceptor components 
used as fluorescent labels. 
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Figure 4.2.  Amide-bridged benzopyrylium and carbopyronin dyes.49,50 
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Figure 4.3.  Bridged naphthoxazinium salts.51 
 
 Bridged naphthoxazinium salts are another type of extended rhodamine 
derivatives with emission maxima above 640 nm.  A few examples of this class of 
compounds are shown in Figure 4.3.  Their absorption wavelengths range from 605 to 
670 nm and their emission maxima vary between 645 and 712 nm.  These bridged 
naphthoxazinium salts exhibit moderate quantum yields and their absorption and 
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emission properties are dependent on the polarity and pH of the solvents used.  
Consequently, they can also be used as acid-base indicators.  
 Bromo-substituted rhodamine derivatives are very useful starting materials for 
preparation of fluorescent dyes via coupling reactions.  A set of four bromo-rhodamines 
is shown in Figure 4.4.  They have favorable fluorescence spectra that range from 532 to 
616 nm and their synthesis is convenient and efficient in the context of obtaining pure 
regioisomers.  Consequently, they are useful synthetic building blocks and have been 
used as acceptor components and incorporated into through-bond energy transfer 
systems via both Sonogashira and Suzuki organometallic coupling reactions with 
fluorescein derivatives.16,52  When these fluorescent systems have been excited by a laser 
source that operates at a single wavelength (e.g. 488 nm, the excitation from an Ar-
laser), they fluoresce at wavelengths characteristic of only the acceptor components.  
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Figure 4.4.  Bromo-substituted rhodamine derivatives.53 
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 The rhodamine-based acceptor components described later in this chapter are 
designed and synthesized mainly for intracellular imaging.  Consequently, they should 
emit with high quantum yields above 650 nm in order to minimize the problems of 
background fluorescence from the components in cells.  Since there are very few 
fluorescent dyes that are consistent with biological samples and emit efficiently above 
650 nm, the design and synthesis of acceptor components that produce long wavelength 
emission is needed.  Although rhodamines have been established to be superior to other 
fluorophores with respect to photostability and long wavelength emission maxima, they 
are not appropriate for intracellular studies since their emission wavelengths are shorter 
than ideal.48  The extended rhodamine derivatives mentioned earlier emit in the range 
640–700 nm and could be converted into the corresponding halogenated acceptor 
components, so that they might act as potential acceptor fragments for the through-bond 
energy transfer system targets.  However, modified rhodamine-based acceptors with 
extended aromatic systems whose synthesis is not that laborious need to be prepared.  
Types of these modified rhodamines are pyrylium cations that are expected to fluoresce 
above 650 nm.  Similar pyrylium cations without amino groups were prepared for other 
reasons before and are known to be highly fluorescent.54-57  One of the target cassettes 
has been designated to have a rhodamine-based donor with one sulfonic acid group to 
improve water solubility coupled with the above designed rhodamine-based acceptor 
with carboxylic acid functionalities for attachment of the dyes to biomolecules (Figure 
4.5).  The synthesis of the rhodamine-based acceptor is described later in detail in the 
next section of this chapter. 
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Figure 4.5.  Target cassette optimized for maximal fluorescence intensity. 
 
4.2 Synthesis of Pyrylium Cations 
The rhodamine-based acceptor fragments that I synthesized are pyrylium cations 
and the starting materials chosen to start their synthesis are 6-acetylaminotetralone and 
2-benzylidene-1-tetralone.  Synthesis of 6-acetylaminotetralone 43 was executed in four 
steps from a cheap commercially available starting material, tetralin (39), according to 
literature procedures (Scheme 4.1).58-61  Thus, Friedel-Crafts acetylation of tetralin (39) 
with acetyl chloride in the presence of aluminum chloride furnished acetyltetralin 40 in 
80 % yield after purification by vacuum distillation.  Condensation of the latter with 
hydroxylamine was performed according to a modified literature procedure and 
furnished the crystalline oxime 41 in 95 % after recrystallization from ethyl acetate.  The 
oxime 41 was subjected to Beckmann rearrangement using benzenesulphonyl chloride in 
pyridine to furnish 6-acetamidotetralin 42 in 60 % yield.  Oxidation of the resulting 6-
 43
acetylaminotetralin with chromium trioxide in acetic acid afforded 6-acetamidotetralone 
43 in 40 % yield. 
 
Scheme 4.1.  Synthesis of 6-Acetylaminotetralone 
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6-Acetamidotetralone 43 is a common intermediate for preparation of both 6-
acetamido-2-benzylidene-1-tetralone and pyrylium cations.  Preparation of 
diamonopyrylium salt 46 is shown in Scheme 4.2.54,62  Thus, condensation of 
bromobenzaldehyde 44 with the readily prepared 6-acetamidotetralone 43 in ethanolic 
potassium hydroxide furnished crystalline 6-acetamido-2-benzylidene-1-tetralone (45) in 
85 % yield after recrystallization from ethanol.  6-Acetamido-2-benzylidene-1-tetralone 
(45) was further subjected to a condensation reaction with 6-acetamidotetralone 43 in the 
presence of boron trifluoride-ether as a hydride abstracting agent to give the pyrylium 
tetrafluoroborate.  Unfortunately, the condensation reaction yielded 1.3 g of mixture of 
diaminopyrylium salt, monoacetamido- and diacetamidopyrylium salts.  A reaction time 
of four hours was not sufficient for complete condensation.   
 44
Scheme 4.2.  Synthesis of Diaminopyrylium Cation 
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Consequently, the reaction was optimized by use of longer reaction times.  
However, after 24 hours, monoacetamido derivative was still present in the reaction 
mixture.  The efforts to isolate the product by recrystallization from various solvent 
systems were unsuccessful, so that other approaches were taken.  Thus, in the attempt to 
isolate diaminopyrylium salt, the counterion was exchanged with tetra(3,5-
trifluoromethylbenzene)boronate (BARF) anion in order to allow convenient 
chromatographic isolation of the product.  Unfortunately, the flash chromatography did 
not help isolate the diaminopyrylium salt either.  HPLC could be used to purify the 
desired product, but its unavailability did not allow me further attempts to isolate it. 
 In addition to diaminopyrylium salt 46, monoaminopyrylium salt 49 was 
prepared following the same procedure as for 46 (Scheme 4.3).  Thus, condensation of 
bromobenzaldehyde 44 with α-tetralone 47 furnished the crystalline 2-benzylidene-1-
tetralone 48 in 80 % yield.  Further condensation of 48 of with 6-acetamidotetralone 43 
afforded the monoaminopyrylium salt 49 that was subjected to the same isolation 
procedure as the one mentioned above for 46. 
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Scheme 4.3.  Synthesis of Monoaminopyrylium Cation 
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4.3 Conclusion 
 New rhodamine-based acceptor components with extended aromatic systems 
were synthesized.  Types of these modified rhodamines are monoamino- and 
diaminopyrylium cations like 46 and 49.  They were prepared from affordable starting 
materials, tetralin and 4-bromo-benzaldehyde.  Synthesis of the intermediate 6-
acetylaminotetralone 43 was executed in four steps starting from tetralin.  2-
Benzylidene-1-tetralones 45 and 48 were prepared by the condensation of 4-bromo-
benzaldehyde with the corresponding tetralones and were then subjected to further 
condensations in the presence of boron trifluoride-ether to give the pyrylium salts.  The 
efforts to isolate the pyrylium salts by repeated recrystallizations from various solvent 
systems and flash chromatography after exchanging the counterion with tetra(3,5-
trifluoromethylbenzene)boronate to allow convenient chromatographic isolation of the 
product were unsuccessful.  It should be possible to isolate the desired target compounds 
using HPLC.  Once isolated, these rhodamine-based acceptors could be potential 
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components to be incorporated into through-bond energy transfer cassettes for 
intracellular imaging. 
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CHAPTER V 
CONCLUSION  
 
A nucleoside analogue, 7-iodo-2′,3′-dideoxy-7-deazaadenosine, has been 
synthesized in 15 steps from affordable starting materials by a series of protection, 
deoxygenation, and iodination steps.  4-Methoxy-2-methylsulfanyl-7H-pyrrolo[2,3-
d]pyrimidine, a common intermediate for the preparation of 7-iodo-2′,3′-dideoxy-7-
deazaguanosine, has also been synthesized in 6 steps.  Triphosphorylation of the 7-iodo-
2′,3′-dideoxy-7-deazaadenosine, coupling the fluorescent dyes to the resulting 
nucleotide, its enzymatic incorporation into a growing DNA strand, and evaluation as 
chain-terminating inhibitors of the DNA polymerases are underway (Figure 5.1). 
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Figure 5.1.  Chain-terminating inhibitor of the DNA polymerase. 
 
Chapter III describes the synthesis of fluorescein-based donor components to be 
incorporated into through-bond energy transfer systems.  Although they are known 
compounds, our efforts have been focused on making more fluorescein-based donors via 
halogenated fluoresceins since they are important synthetic building blocks used to make 
various dyes.  The synthesis of fluorescein-based donor fragment has been executed in 
five steps from 1,3-dihydroxybenzene and phthalic anhydride.  The donor fluorescein 
carboxylate has been alkylated with the tert-butyl ester of 6-bromohexanonoic acid to 
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provide a handle for attachment to biomolecules.  In the context of regioisomerically 
pure halofluoresceins, besides the synthesis of pure regioisomers of bromofluorescein 
derivatives, 5-iodosulfofluorescein and pure regioisomers of 5-nitrofluorescein diacetate, 
as an intermediate in the synthesis of 5-iodofluoresceins, have been synthesized.   
Chapter IV describes the synthesis of new rhodamine-based acceptor components 
with extended aromatic systems.  Types of these modified rhodamines are monoamino- 
and diaminopyrylium cations like 46 and 49.  They were prepared from affordable 
starting materials, tetralin and 4-bromo-benzaldehyde.  The efforts to isolate the 
pyrylium salts by repeated recrystallizations from various solvent systems and flash 
chromatography after exchanging the counterion with tetra(3,5-
trifluoromethylbenzene)boronate (BARF) to allow convenient chromatographic isolation 
of the product were unsuccesssful.   
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Figure 5.2.  Target cassette optimized for maximal fluorescence intensity described in  
                     Chapter IV. 
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Isolation of the desired target compounds might be accomplished using HPLC.  Once 
isolated, these rhodamine-based acceptors are potential components to be incorporated 
into through-bond energy transfer cassettes for intracellular imaging (Figure 5.2). 
 In summary, this thesis describes the synthesis of a nucleoside analogue, and 
donor and acceptor components to be incorporated into through-bond energy transfer 
systems designed for DNA sequencing and other applications in biotechnology. 
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CHAPTER VI 
EXPERIMENTAL SECTION 
 
General Procedures.  High field NMR spectra were recorded on Inova 300 (1H 
at 300 MHz, 13C at 75 MHz) and Mercury 300 (1H at 300 MHz) NMR spectrometers.  
Chemical shifts are reported in units of ppm relative to solvent (CDCl3:  7.27 ppm for 1H 
and 77.0 for 13C; D2O: 4.63 ppm for 1H; DMSO-d6: 2.50 ppm for 1H and 39.5 for 13C; 
CD3OD: 3.30 ppm for 1H and 49.0 for 13C; Acetone-d6: 2.04 ppm for 1H and 29.9 for 
13C).  Mass spectra were obtained from the Mass Spectrometry Applications Laboratory 
at Texas A&M University.  Thin layer chromatography was performed using silica gel 
60 F254.  Flash chromatography was performed using silica gel (230-600 mesh).  
CH2Cl2, THF, DMF, MeOH, CH3CN, Et2O, pyridine, triethylamine, and toluene were 
distilled from appropriate drying agents.  Other chemicals were purchased from 
commercial suppliers and used as received. 
 
 
EtO
OEt
COOEt
CN
3  
 
 Diethoxyethylcyanoacetate (3).   A mixture of bromoacetal 1 (320 g, 1.62 
moles), ethylcyanoacetate 2 (912 g, 8.07 mol), anhydrous potassium carbonate (224 g), 
and sodium iodide (16 g) was stirred under reflux at 145–148 oC until the evolution of 
carbon dioxide ceased and then for a further 4 h at 145–148 oC.  The mixture was cooled 
and dissolved in water (1600 mL) and Et2O (1600 mL). The organic layer was washed 
with water, and the aqueous solution was extracted with Et2O.  The combined organic 
layers were dried over MgSO4.  Evaporation of the solvent under reduced pressure, and 
purification of the crude product by vacuum distillation gave the ester 3 (111 g, 30 %) as 
a colorless oil, bp 111-115 oC/1.3 mm Hg:  1H-NMR (CDCl3, 300 MHz): δ (ppm) 1.20 
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(t, J = 7 Hz, 6H), 1.30 (t, J = 9Hz, 3H), 2.23 (t, J = 6.0 Hz, 2H), 3.50 (m, 1H), 3.65 (m, 
4H), 4.23 (q, 2H), 4.70 (t, J = 6.0 Hz, 1H). 
Literature Data: 1H-NMR (CDCl3, 300 MHz): δ (ppm) 1.20 (t, 6H), 1.32 (t, 3H), 2.23 (t, 
2H), 3.43 (m, 1H), 3.60 (m, 4H), 4.23 (q, 2H), 4.67 (t, 1H). 
Seela, F.; Richter, R. Chem. Ber. 1978, 111, 2925-2930.  
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 6-Amino-5-(2,2-diethoxy-ethyl)-2-mercapto-pyrimidin-4-ol (4).  To a solution 
of sodium ethoxide (from 0.45 g of Na) in absolute ethanol (10 mL) was added thiourea 
(0.9 g, 11.8 mmol), followed by the ester 3 (2.29 g, 10 mmol).  After the reaction 
mixture was heated at reflux for 12 h, it was cooled to room temperature and treated with 
glacial acetic acid (1.2 mL) and water (12.5 mL).  The precipitated solid was collected 
by filtration to give the acetal 4 (2.00 g, 80 %) as a white solid: 1H-NMR (DMSO-d6, 
300 MHz): δ (ppm) 1.10 (t, J = 7.0 Hz, 6H), 2.43 (d, J = 6.2 Hz, 2H), 3.40-3.60 (m, 4H), 
4.50 (t, J = 6.2 Hz, 1H), 6.05 (s, 2H), 11.4 (s, 1H), 11.7 (s, 1H). 
Literature Data: 1H-NMR (DMSO-d6, 300 MHz): δ (ppm) 1.07 (t, J = 7 Hz, 6H), 2.43 (d, 
J = 6 Hz, 2H), 3.42-3.45 (m, J = 7 Hz , 4H), 4.48 (t, J = 6 Hz, 1H), 6.03 (s, 2H), 11.4 (s, 
1H), 11.7 (s, 1H). 
Seela, F.; Richter, R. Chem. Ber. 1978, 111, 2925-2930.  
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 6-Amino-5-(2,2-diethoxy-ethyl)-pyrimidin-4-ol (5).  To a solution of 4 (2.59 g, 
10 mmol), water (125 mL), and ammonium hydroxide (8 mL) was added Raney nickel 
(8 mL).  After the reaction mixture was heated at reflux for 5 h with stirring, it was 
filtered while hot and evaporated under reduced pressure to give the title compound 5 
(2.00 g, 90 %) as a white solid: 1H-NMR (DMSO-d6, 300 MHz): δ (ppm) 1.18 (t, J = 9.0 
Hz, 6H), 2.65 (d, J = 6.3 Hz, 2H), 3.5-3.8 (m, 4H), 4.6 (t, J = 6.3 Hz, 1H), 6.10 (s, 2H), 
7.75 (s, 1H). 
Davoll, J. J. Chem. Soc. 1960, 131-138. 
 
N
O
HN
N
H
6  
 
3,7-Dihydro-pyrrolo[2,3-d]pyrimidin-4-one (6).  To a solution of compound 5 
(1.0 g, 4.4 mmol) in water (10 mL) was added 0.2 mL of aqueous HCl.  The reaction 
mixture was stirred at room temperature for 36 h.  The solid compound was filtered and 
dried in the oven to give the pyrimidone 6 (380 mg, 65 %) as a white solid: 1H-NMR 
(DMSO-d6, 300 MHz): δ (ppm) 6.45 (d, J = 2.4 Hz, 1H), 7.02 (d, J = 2.4 Hz, 1H), 7.85 
(s, 1H). 
Literature Data: 1H-NMR (DMSO-d6, 300 MHz): δ (ppm) 6.42 (m, 1H), 7.00 (m, 1H), 
7.82 (s, 1H). 
Seela, F.; Richter, R. Chem. Ber. 1978, 111, 2925-2930. 
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4-Chloro-7H-pyrrolo[2,3-d]pyrimidine (7).  A mixture of compound 6 (800 
mg, 5.9 mmol) and phosphoryl chloride (8 mL) was refluxed for 4 h.  Phosphoryl 
chloride was removed in vacuo, and the residue was treated with crushed ice, neutralized 
by NaHCO3 to pH 7 and then extracted with ether (4 x 25 mL).  The ether extracts were 
combined, dried over anhydrous MgSO4 and evaporated under reduced pressure to give 
the desired product 7 (360 mg, 40 %) after recrystallization from EtOAc as a white solid: 
1H-NMR (DMSO-d6, 300 MHz): δ (ppm) 6.61 (d, J = 3.6 Hz, 1H), 7.70 (d, J = 3.6 Hz, 
1H), 8.60 (s, 1H); MS (ESI): m/z 154 (M+H)+. 
Literature Data: 1H-NMR (DMSO-d6, 300 MHz): δ (ppm) 6.60 (d, J = 4 Hz, 2Hz, 1H), 
7.75 (d, J = 4 Hz, 2.5 Hz, 1H), 8.60 (s, 1H);  
Lupke, U.; Seela, F. Chem. Ber. 1979, 112, 3526-3529. 
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1α/β-O-Methyl-2-deoxy-D-ribofuranosyl bis(p-toluate) (10).  To a solution of 
2-deoxy-D-ribose 8 (5 g, 37.3 mmol) in MeOH (60 mL) was added 1 % methanolic HCl 
(10 mL prepared by adding 0.9 mL of acetyl chloride to 50 mL of MeOH).  The reaction 
mixture was stirred at room temperature for 30 min and neutralized to pH 7 by sodium 
bicarbonate.  After filtration, the methanol was removed by repeated coevaporation with 
pyridine (1 x 25 mL and 2 x 12 mL) to give the crude compound 9, which was used 
without any purification for acylation.  The residue was dissolved in pyridine (30 mL), 
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cooled to 0 oC and p-toluoyl chloride was added dropwise.  The reaction mixture was 
stirred at room temperature overnight.  The solution was then diluted with cold water (75 
mL) and extracted 3 times with CH2Cl2.  The organic extracts were combined, washed 
twice with NaHCO3, once with 2N HCl, and once with water, then dried over anhydrous 
NaHCO3 and evaporated under reduced pressure to furnish the crude mixture of bis(4-
methyl benzoates) 10.  The α-isomer was isolated by flash chromatography eluting with 
CH2Cl2 to give the pure 10 (9.00 g, 63 %) as light yellow oil: 1H-NMR (CDCl3, 300 
MHz): δ (ppm) 2.15, 2.30 (m, 2H), 2.40 (s, 6H), 3.40 (s, 3H), 4.50 (m, 3H), 5.10 (dd, 
1H), 5.30 (dt, 1H), 7.20, 7.90 (m, 8H).  
Literature Data: 1H-NMR (CDCl3, 300 MHz): δ (ppm) 2.20, 2.50 (m, 2H), 2.37 (s, 6H), 
3.41 (s, 3H), 4.57 (bt, 3H), 5.15 (dd, 1H), 5.35 (dt, 1H), 7.15, 7.98 (m, 8H). 
Takeshita, M; Chang C.; Johnson F.; Will, S.; Grollman, A. P. J. Biol. Chem. 1987, 262, 
10171-10179. 
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1α-Chloro-2-deoxy-D-ribofuranosyl bis(p-toluate) (11).  To a solution of 10 
(3.84 g, 9.9 mmol) in acetic acid (6 mL) was slowly added a saturated solution of HCl in 
acetic acid (9.6 mL prepared by adding 2.4 mL of acetyl chloride to a solution of 12.2 
mL acetic acid and 0.6 mL water on cooling).  After an additional amount of acetyl 
chloride (0.8 mL) was added, the chloride precipitated.  The crystals were collected by 
filtration, washed with cold ether, and dried in vacuo to give the chloride 11 (2.2 g, 57 
%) as a white crystalline solid: 1H-NMR (CDCl3, 300 MHz): δ (ppm) 2.41 (s, 6H), 2.80 
(m, 2H), 4.60 (m, 2H), 4.80 (m, 1H), 5.60 (dt, 1H), 6.50 (dd, J = 4.3 Hz, 0.6 Hz, 1H), 
7.20 (d, J = 8.4 Hz, 4H) 7.90, 8.10 (dd, J = 8.4 Hz, 1.2 Hz, 4H). 
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Literature Data: 1H-NMR (CDCl3, 300 MHz): δ (ppm) 2.41 (s, 6H), 2.75 (m, 2H), 4.60 
(bd, 2H), 4.78 (m, 1H), 5.54 (dt, 1H), 6.45 (dd, J = 4.0 Hz, 0.5 Hz, 1H), 7.17, 8.04 (dd, 
8H).  
Takeshita, M; Chang C.; Johnson F.; Will, S.; Grollman, A. P. J. Biol. Chem. 1987, 262, 
10171-10179. 
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 4-Chloro-7-(2-deoxy-3,5-di-O-(p-toluoyl)-β-D-erythro-pentofuranosyl)-7H-
pyrrolo[2,3-d]pyrimidine (12).  To a suspension of compound 7 (1.02 g, 6.65 mmol) in 
dry acetonitrile (42 mL) was added sodium hydride (50 % in oil, 0.28 mg) and the 
mixture was stirred at room temperature for 30 min.  Compound 11 was added 
portionwise with stirring.  The reaction mixture was further stirred at 50 oC for 8 h and 
then was filtered to remove any insoluble material.  The filtrate was evaporated under 
reduced pressure and the oily residue was purified by flash chromatography eluting with 
20 % EtOAc/hexanes.  Crystallization from ethanol yielded the title compound 12 (2.4 g, 
71 %) as white crystals: 1H-NMR (CDCl3, 300 MHz): δ (ppm) 2.41, 2.49 (s, 6H), 2.78 
(m, 1H), 3.18 (m, 1H), 4.56 (m, 3H), 5.76 (m, 1H), 6.75 (d, J = 3.5 Hz, 1H), 6.76 (m, 
1H), 7.35, 7.90 (m, 9H), 8.65 (s, 1H), 8.65 (s, 1H); 13C-NMR (DMSO-d6, 75 MHz): δ 
(ppm) 21.9, 36.7, 64.8, 75.5, 82.1, 84.3, 100.8, 118.3, 129.4, 151.4, 151.6, 151.7, 166.5; 
MS (ESI): m/z 506 (M+H)+. 
Literature Data: 1H-NMR (DMSO-d6, 300 MHz): δ (ppm) 2.37, 2.40 (s, 6H), 2.77 (m, 
1H), 3.18 (m, 1H), 4.60 (m, 3H), 5.77 (m, 1H), 6.75 (d, J = 3.7 Hz, 1H), 6.78 (m, 1H), 
7.34, 7.91 (m, 9H), 8.65 (s, 1H), 8.65 (s, 1H); 13C-NMR (DMSO-d6, 75 MHz): δ (ppm) 
21.3, 36.1, 64.2, 75.0, 81.5, 84.0, 100.2, 117.7, 128.7, 150.7, 151.0, 151.1, 166.5. 
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Seela, F.; Muth, H.-P.; Bindig, U. Synthesis 1988, 670-674.  
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4-Chloro-7-(2-deoxy-β-D-erythro-pentofuranosyl)-7H-pyrrolo[2,3-
d]pyrimidine (13).  Compound 12 (7.3 g, 14.3 mmol) was added to a solution of 7N 
NH3/MeOH (300 mL).  The reaction mixture was stirred at room temperature for 5 d.  
The solution was evaporated in vacuo and the residue was adsorbed into silica and 
purified by flash chromatography eluting with 10 % MeOH/CH2Cl2 to give the target 
compound 13 (2.7 g, 70 %) as a white solid: 1H-NMR (DMSO-d6, 300 MHz): δ (ppm) 
2.10, 2.30 (m, 2H), 3.55 (m, 2H), 3.85 (m, 1H), 4.38 (m, 1H), 4.97 (m, J = 5.0 Hz, 1H), 
5.30 (m, J = 3.9 Hz, 1H), 6.58 (m, 1H), 6.60 (d, J = 3.9 Hz, 1H), 7.70 (d, J = 3.6 Hz, 
1H), 8.44 (s, 1H); 13C-NMR (DMSO-d6, 75 MHz): δ (ppm) 39.9, 62.5, 71.8, 84.0, 88.0, 
100.7, 118.0, 129.5, 152.0, 153.0, 153.5; MS (ESI): m/z 270 (M+H)+. 
Literature Data: 1H-NMR (DMSO-d6, 300 MHz): δ (ppm) 2.18, 2.40 (m, 2H), 3.57 (m, 
2H), 3.87 (m, 1H), 4.40 (m, 1H), 5.00 (m, J = 5.4 Hz, 1H), 5.35 (m, J = 4.2 Hz, 1H), 
6.66 (m, 1H), 6.72 (d, J = 3.8 Hz , 1H), 7.99 (d, J = 3.88 Hz , 1H), 8.66 (s, 1H); 13C-
NMR (DMSO-d6, 75 MHz): δ (ppm) 39.9, 61.8, 70.9, 83.4, 87.7, 99.7, 117.4, 128.5, 
150.5, 150.6, 150.8.  
Seela, F.; Muth, H.-P.; Bindig, U. Synthesis 1988, 670-674.  
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 4-Chloro-7-(2-deoxy-β-D-erythro-pentofuranosyl)-5′-O-pivaloyl-7H-
pyrrolo[2,3-d]pyrimidine (14).  To a solution of the diol 13 (2.6 g, 9.7 mmol) in 
pyridine (100 mL) was added pivaloyl chloride (1.75 g, 14.6 mmol) and the reaction 
mixture was stirred at 0 oC for 5 h.  The solution was then evaporated under reduced 
pressure, and the residue was adsorbed onto silica and purified by flash chromatography 
eluting with 50 % EtOAc/Hexanes to give the title compound 14 (1.7 g, 50 %) as white 
crystals: 1H-NMR (CDCl3, 300 MHz): δ (ppm) 1.23 (s, 9H), 2.45-2.70 (m, 2H), 4.20 (m, 
2H), 4.30 (m, 1H), 4.60 (m, 1H), 6.68 (d, J = 3.6 Hz, 1H), 6.70 (m, 1H), 7.44 (d, J  = 3.6 
Hz, 1H), 8.66 (s, 1H);  13C-NMR (CDCl3, 75 MHz): δ (ppm) 27.5, 39.2, 40.6, 64.0, 72.0, 
84.2, 84.4, 101.0, 118.2, 126.5, 151.0, 151.1, 152.4, 178.9; MS (ESI): m/z 354 (M+H)+. 
Cocuzza, A. J. Tetrahedron Lett. 1988, 29, 4061-4064. 
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 4-Chloro-7-(2-deoxy-β-D-erythro-pentofuranosyl)-5′-O-pivaloyl-3′-O-
phenoxythiocarbonyl-7H-pyrrolo[2,3-d]pyrimidine (15).  To a solution of 5′-pivalate 
14 (1.06 g, 3 mmol) in dichloromethane (21 mL), 4-dimethylaminopyridine (0.9 g, 7.5 
mmol) and O-phenyl chlorothionocarbonate (0.8 mL, 5.9 mmol) were added.  After 
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stirring the reaction mixture at room temperature for 4 h, additional dichloromethane (14 
mL) was added, and the solution was washed with 0.5 N hydrochloric acid, 0.5 N 
sodium hydroxide, and brine.  The combined organic layers were dried over Na2SO4 and 
evaporated under reduced pressure.  The residue was adsorbed onto silica and purified 
by flash chromatography eluting with 40 % EtOAc/Hexanes to give the title compound 
15 (1.3 g, 90 %) as white crystals: 1H-NMR (CDCl3, 300 MHz): δ (ppm) 1.22 (s, 9H), 
2.75-2.95 (m, 2H), 4.40 (m, 2H), 4.60 (m, 1H), 5.85 (m, 1H), 6.60 (d, J = 4.1 Hz, 1H), 
6.80 (m, 1H), 7.10-7.30 (m, 5H), 7.40 (d, J = 4.1 Hz, 1H), 8.50 (s, 1H); 13C-NMR 
(CDCl3, 75 MHz): δ (ppm) 27.5, 37.8, 39.1, 64.3, 81.8, 83.6, 84.7, 101.3, 118.6, 126.1, 
151.2, 151.4, 152.7, 178.4, 194.3; MS (ESI): m/z 490 (M+H)+. 
Cocuzza, A. J. Tetrahedron Lett. 1988, 29, 4061-4064.  
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4-Chloro-7-(2,3-deoxy-β-D-erythro-pentofuranosyl)-5′-O-pivaloyl-7H-
pyrrolo[2,3-d]pyrimidine (15).  To a stirred solution of 15 (1.7 g, 3.4 mmol) and 2,2′-
azobis(2-methyl)propionitrile (AIBN) (0.1 g, 0.62 mmol) in 103 mL of dry toluene, was 
added tri-n-butyltin hydride (1.34 g, 4.6 mmol) and the reaction mixture was stirred at 
110 oC for 1 h.  After the reaction mixture had been cooled, it was diluted with 80 mL of 
ether and washed with 80 mL of 10 % aqueous potassium fluoride and brine.  The 
combined organic layers were dried over anhydrous sodium sulfate and evaporated 
under reduced pressure.  The residue was adsorbed onto silica and purified by flash 
chromatography eluting with 1.5 % MeOH/CH2Cl2 to give the title compound 16 (0.75 
g, 64 %) as light yellow oil: 1H-NMR (CDCl3, 300 MHz): δ (ppm) 1.20 (s, 9H), 2.10-
2.50 (m, 4H), 4.25 (m, 2H), 4.40 (m, 1H), 6.53 (dd, J = 4.5 Hz, 2.4 Hz, 1H), 6.62 (d, J = 
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3.6 Hz, 1H), 7.51 (d, J = 3.6 Hz, 1H), 8.61 (s, 1H);  13C-NMR (CDCl3, 75 MHz): δ 
(ppm) 26.8, 27.4, 32.6, 39.0, 65.5, 78.6, 85.2, 100.3, 118.3, 126.4, 150.8, 150.8, 152.2, 
178.4; MS (ESI): m/z 338 (M+H)+. 
Cocuzza, A. J. Tetrahedron Lett. 1988, 29, 4061-4064.  
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 4-Chloro-5-iodo-7-(2,3-deoxy-β-D-erythro-pentofuranosyl)-5′-O-pivaloyl-7H-
pyrrolo[2,3-d]pyrimidine (15).  To a solution of pivalate 16 (0.75 g, 2.2 mmol in 66 
mL CH2Cl2) was added a solution of iodine monochloride (0.34 mL in 3.5 mL CH2Cl2).  
The reaction mixture was stirred at room temperature for 4 h and then was partitioned 
between dichloromethane and aqueous sodium hydrosulfite.  The organic layer was 
washed with aqueous sodium bicarbonate and brine, dried over sodium sulfate, and 
evaporated under reduced pressure.  The residue was triturated with CH2Cl2/ether to give 
the title compound 17 (935 mg, 90 %) as a light yellow solid: 1H-NMR (CDCl3, 300 
MHz): δ (ppm) 1.26 (s, 9H), 2.10-2.60 (m, 4H), 4.33 (m, 2H), 4.40 (m, 1H), 6.54 (dd, J 
= 3.6 Hz, 3.3 Hz, 1H), 7.68 (s, 1H), 8.63 (s, 1H);   13C-NMR (CDCl3, 75 MHz): δ (ppm) 
26.4, 27.5, 33.1, 39.2, 52.1, 65.1, 79.1, 85.5, 123.7, 131.8, 151.0, 151.5, 152.9; 178.6; 
MS (ESI): m/z 464 (M+H)+. 
Cocuzza, A. J. Tetrahedron Lett. 1988, 29, 4061-4064. 
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 7-Iodo-2′,3′-dideoxy-7-deazaadenosine (18).  Compound 17 (0.89 g, 1.9 mmol) 
was added to a solution of 7N NH3/MeOH (160 mL) in a pressure flask well sealed.  The 
reaction mixture was stirred at 120 oC for 18 h.  The solution was evaporated in vacuo 
and the residue was adsorbed into silica and purified by flash chromatography eluting 
with 5% MeOH/CH2Cl2 to give the target compound 18 (630 mg, 90 %) as a white solid: 
1H-NMR (DMSO-d6, 300 MHz): δ (ppm) 2.10 - 2.40 (m, 4H), 3.50 (m, 2H), 4.10 (m, 
1H), 4.95 (t, J = 5.4 Hz, 1H), 6.32 (dd, J = 6.6 Hz, 4.2 Hz, 1H), 6.65 (s, 2H), 7.67 (s, 
1H); 8.09 (s, 1H) 13C-NMR (DMSO-d6, 75 MHz): δ (ppm) 26.5, 32.5, 52.0, 63.8, 81.7, 
84.3, 103.7, 127.3, 150.1, 152.6, 157.8; MS (ESI): m/z 361 (M+H)+. 
Literature Data: 1H-NMR (DMSO-d6, 300 MHz): δ (ppm) 2.00 - 2.30 (m, 4H), 3.49, 
3.59 (m, 2H), 4.04 (m, J = 3.5 Hz, 1H), 4.95 (t, J = 5.5 Hz, 1H), 6.34 (dd, J = 4.4 Hz, 6.8 
Hz, 1H), 6.65 (s, 2H), 7.67 (s, 1H); 8.09 (s, 1H). 
Hobbs, F. W.; Cocuzza, A. US Patent 5047519, 1988. 
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 6-Amino-5-(2,2-diethoxy-ethyl)-2-methylsulfanyl-pyrimidin-4-ol (19).  
Compound 4 (30 g, 0.132 mol) was dissolved in 1N NaOH (17 mL, 0.12 mol) and 
dimethyl sulfate (12.47 mL, 0.132 mol) was slowly added over a period of 10 min.  The 
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reaction mixture was stirred at room temperature for 2 h.  The precipitated solid was 
collected by filtration and washed with water to give the 2-methylthiopyrimidine 19 
(25.5 g, 80 %) as a white solid: 1H-NMR (DMSO-d6, 300 MHz): δ (ppm) 0.98 (t, J = 7.2 
Hz, 6H), 1.98 (s, 3H), 2.4 (m, 2H), 3.2-3.5 (m, 4H), 4.45 (t, J = 6 Hz, 1H), 5.9 (s, 2H, 
NH2), 11.6 (s, 1H, NH). 
Literature Data: 1H-NMR (DMSO-d6, 300 MHz): δ (ppm) 1.10 (t, J = 7 Hz, 6H), 2.40 
(m, 2H), 2.43 (s, 3H), 3.47 (m, 4H), 4.55 (t, J = 6 Hz, 1H), 6.07 (NH2).  
Seela, F.; Richter, R. Chem. Ber. 1978, 111, 2925-2930. 
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2-Methylsulfanyl-3,7-dihydro-pyrrolo[2,3-d]pyrimidin-4-one (20).  In the 
same manner as for 6, the title compound was prepared by using the compound 19 (2.73 
g, 10 mmol), water (50 mL), aqueous HCl (1 mL).  The solid compound was filtered and 
dried in the oven to give the title compound 20 (1.26 g, 70 %) as a white solid: 1H-NMR 
(DMSO-d6, 300 MHz): δ (ppm) 2.50 (s, 3H), 6.30 (d, J = 3.8 Hz, 1H), 6.85 (d, J = 3.8 
Hz, 1H). 
Literature Data: 1H-NMR (DMSO-d6, 300 MHz): δ (ppm) 2.53 (s, 3H), 6.37 (d, J = 4 
Hz, 1H), 6.88 (d, J = 4 Hz, 1H).  
Seela, F.; Richter, R. Chem. Ber. 1978, 111, 2925-2930. 
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 4-Chloro-2-methylsulfanyl-7H-pyrrolo[2,3-d]pyrimidine (21).  In the same 
manner as for 7, the title compound was prepared by using the compound 20 (1.81 g, 1 
mmol) and phosphoryl chloride (20 mL).  The crude product was recrystallized from 
EtOAc to give the title compound 21 (0.76 g, 40 %) as a white solid: 1H-NMR (DMSO-
d6, 300 MHz): δ (ppm) 2.57 (s, 3H), 6.50 (d, J = 3.0 Hz, 1H), 7.56 (d, J = 3.0 Hz, 1H). 
Literature data: 1H-NMR (DMSO-d6, 300 MHz): δ (ppm) 2.60 (s, 3H), 6.50 (m, 1H), 
7.50 (m, 1H).  
Lupke, U.; Seela, F. Chem. Ber. 1979, 112, 3432-3440. 
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 4-Methoxy-2-methylsulfanyl-7H-pyrrolo[2,3-d]pyrimidine (22).  Compound 
22 (1.99 g, 10 mmol) was suspended in dry MeOH (50 mL) containing sodium 
methoxide (1.24 g, 2.23 mmol), then the mixture was refluxed for 90 h.  The reaction 
mixture was neutralized to pH 7 by Dowex basic resin.  The resin was removed by 
filtration, and the filtrate was evaporated in vacuo.  The crude product was recrystallized 
from 10 % aqueous MeOH to give the title compound 22 (1.36 g, 70 %) as fine colorless 
crystals: 1H-NMR (CDCl3, 300 MHz): δ (ppm) 2.60 (s, 3H), 4.20 (s, 3H), 6.45 (d, J = 
3.3 Hz, 1H), 7.0 (d, J = 3.3 Hz, 1H), 11.8 (s, 1H, -NH). 
Literature data: 1H-NMR (DMSO-d6, 300 MHz): δ (ppm) 2.56 (s, 3H), 4.03 (s, 3H), 6.39 
(d, J = 3.5 Hz, 1H), 7.18 (d, J = 3.5 Hz, 1H), 11.8 (s, -NH). 
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Lupke, U.; Seela, F. Chem. Ber. 1979, 112, 3432-3440. 
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5-Bromofluorescein diacetate (26).  A mixture of 4-bromophthalic anhydride 
24 (20 g, 88 mmol) and resorcinol 23 (19.4 g, 176 mmol) was heated at 200 oC with 
stirring for 12 h.  The reaction mixture was then cooled to room temperature, and the 
solid product was collected and ground in a mortar to afford 34 g of a mixture of 5- and 
6-bromofluorescein.  The crude bromofluorescein mixture, which was used further 
without any purification in the acylation, was dissolved in 140 mL of acetic anhydride 
and refluxed for 3 h.  The reaction mixture was then cooled to room temperature and 
pale yellow crystals precipitated.  The crystals were collected by filtration, rinsed with 
cold acetic anhydride and ethanol and dried in vacuo to give 11 g of a mixture of 5- and 
6-isomers 25a and 25b, but with the 5-bromo isomer 25a representing the major product.  
The mother liquor was concentrated to half the volume, allowed to stand for about 20 h, 
and the crystals formed were collected by filtration and dried in vacuo.  The first and 
second crops of crystals were recrystallized from acetic anhydride twice to give 
regioisomerically pure 5-bromofluorescein diacetate 26 (12.2 g, 28 %) as a light brown 
solid: 1H-NMR (CDCl3, 300 MHz): δ (ppm) 2.45 (s, 6H), 6.87 (m, 4H), 7.13 (dd, J = 1.5 
Hz, 0.8 Hz, 2H), 7.83 (dd, J = 8.3 Hz, 1.5 Hz,1H), 8.19 (dd, J = 1.5 Hz, 0.8 Hz, 1H). 
Literature Data: 1H-NMR (CDCl3, 300 MHz): δ (ppm) 2.33 (s, 6H), 6.84 (m, 4H), 7.09 
(dd, J = 1.8 Hz, 0.6 Hz, 1H), 7.81 (dd, J = 8.1 Hz, 1.8 Hz, 1H), 8.17 (dd, J = 1.8 Hz, 0.6 
Hz, 1H).  
Jiao, G.-S.; Han, J. W.; Burgess, K. J. Org. Chem. 2003, 68, 8264-8267. 
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6-Bromofluorescein diacetate was also isolated.  The mother liquors from the 
recrystallization of 5-bromofluorescein diacetate were combined and acetic anhydride 
was evaporated under reduced pressure.  The solid was then dissolved in ethanol and 
allowed to stand overnight.  The crystals formed were collected by filtration and 
recrystallized from ethanol to afford 6-bromofluorescein diacetate. 
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5-(2-Trimethylsilylethynyl)fluorescein diacetate (27).  5-Bromofluorescein 
diacetate 26 (500 mg, 1.0 mmol), copper iodide (9.5 mg, 0.05 mmol), and palladium 
tetrakis triphenylphosphine (35 mg, 0.05 mmol) were combined in 1 mL of THF in a 
Schlenk flask.  Triethyl amine (1.4 mL, 10 mmol) was added to the above mixture, 
followed by trimethylsilyl acetylene (0.28 mL, 2 mmol) and the reaction mixture was 
stirred at 70 oC for 5h.  The mixture was then cooled to room temperature and stirring 
was continued overnight.  The solution was then filtered over Celite and washed with 
THF.  The solvent was evaporated under reduced pressure, Et2O was added and 
extracted with 0.1 M HCl (3 x 40 mL).  The aqueous layers were extracted once with 25 
mL of Et2O, the organic extracts were combined and dried over anhydrous MgSO4, and 
the solvent was evaporated under reduced pressure.  The product was recrystallized from 
ethanol to afford 5-(2-trimethylsilylethynyl) fluorescein diacetate 27 (388 mg, 75 %) as a 
light brown powder.  1H-NMR (CDCl3, 300 MHz): δ (ppm) 0.28 (s, 9 H), 2.32 (s, 6H), 
6.82 (m, 4H), 7.10 (m, 2H), 7.14 (d, J = 8.3 Hz, 1H), 7.74 (dd, J = 8.3 Hz, 1.5 Hz, 1H), 
8.10 (s, 1H). 
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Literature Data: 1H-NMR (CDCl3, 300 MHz): δ (ppm) 0.29 (s, 9 H), 2.33 (s, 6H), 6.82 
(m, 4H), 7.10 (m, 2H), 7.13 (d, J = 8.1 Hz, 1H), 7.75 (dd, J = 8.1 Hz, 1.2 Hz, 1H), 8.10 
(s, 1H).  
Jiao, G.-S.; Thoresen, L. H.; Burgess, K. J. Am. Chem. Soc. 2003, 125, 14668-14669. 
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 5-Ethynylfluorescein (28).  5-(2-Trimethylsilylethynyl)fluorescein diacetate 27 
(318 mg, 0.62 mmol) and potassium carbonate (428 mg, 3.10 mmol) were combined in 6 
mL of 1:1 MeOH/THF.  After the reaction mixture was stirred for 20 h at 25 oC, it was 
poured into 40 mL of water and acidified with concentrated HCl to pH 2.  The 
precipitate that formed upon acidification was collected by filtration, rinsed with water 
and dried in vacuo to afford the desired product 28 (177 mg, 80 %) as an orange solid.  
1H-NMR (acetone-d6, 300 MHz): δ (ppm) 3.94 (s, 1H), 6.69 (dd, J = 8.3 Hz, 2.7 Hz, 
2H), 6.75 (d, J = 8.3 Hz, 2H), 6.80 (d, J = 2.7 Hz, 2H), 7.35 (dd, J = 7.8 Hz, 0.8 Hz, 1H), 
7.91 (dd, J = 7.8 Hz,  1.3 H, 1H), 8.06 (dd, J = 1.3 Hz, 0.4 Hz, 1H). 
Literature Data: 1H-NMR (acetone-d6, 500 MHz): δ (ppm) 3.91 (s, 1H), 6.62 (dd, J = 8.5 
Hz, 2.5 Hz, 2H), 6.70 (d, J = 8.5 Hz, 2H), 6.75 (d, J = 2.5 Hz, 2H), 7.31 (dd, J = 8 Hz, 1 
Hz, 1H), 7.87 (dd, J = 8 Hz, 1.5 Hz, 1H), 8.01 (dd, J = 1.5 Hz, 0.5 Hz, 1H).  
Jiao, G.-S.; Thoresen, L. H.; Burgess, K. J. Am. Chem. Soc. 2003, 125, 14668-14669. 
 66
O OHO
O C 2
tBu
O
29
O
 
 
5-Ethynylfluorescein-(5-tert-butoxycarbonyl)-pentyl ester (29).  To a solution 
of 5-ethynylfluorescein 28 (168 mg, 0.47 mmol) and tert-butyl ester of 6-
bromohexanonoic acid (148 mg, 0.58 mmol) in 4.5 mL of DMF was added potassium 
carbonate (85 mg, 0.61 mmol).  After the reaction mixture was stirred at 25 oC for 24 h, 
it was adsorbed onto silica, then purified by flash chromatography using 10 % 
MeOH/CHCl3 to give 29 (151 mg, 60 %) as an orange solid: 1H-NMR (CD3OD, 300 
MHz): δ (ppm) 0.9 – 1.06 (m, 2H), 1.24 – 1.30 (m, 2H), 1.37 – 1.40 (m, 2H), 1.44 (s, 
9H), 2.10 (t, J = 7.5 Hz, 2H), 3.84 (s, 1H), 3.95 (t, J = 6 Hz, 2H), 6.69 (dd, J = 9 Hz, 1.8 
Hz, 2H), 6.73 (d, J = 2.0 Hz, 2H), 7.02 (d, J = 9 Hz, 2H), 7.42 (d, J = 7.8 Hz, 1H), 7.89 
(dd, J = 7.8 Hz, 1.2 Hz, 1H), 8.30 (d, J = 1.2 Hz, 1H); 13C-NMR (CD3OD, 75 MHz): δ 
(ppm) 24.59, 25.30, 27.37, 27.95, 34.98, 65.71, 78.30, 80.30, 80.81, 81.40, 103.41, 
115.20, 121.80, 124.80, 130.73, 130.97, 131.25, 134.00, 134.43, 135.78, 154.25, 157.75, 
165.00, 173.60.  
Literature Data: 1H-NMR (CD3OD, 500 MHz): δ (ppm) 0.9 - 1.01 (m, 2H), 1.23 – 1.29 
(m, 2H), 1.35 – 1.41 (m, 2H), 1.42 (s, 9H), 2.08 (t, J = 7.3 Hz, 2H), 3.83 (s, 1H), 3.94 (t, 
J = 7.3 Hz, 2H), 6.70 (dd, J = 9.3 Hz, 2.0 Hz, 2H), 6.73 (d, J = 2.0 Hz, 2H), 7.01 (d, J = 
9.3 Hz, 2H), 7.42 (d, J = 7.8 Hz, 1H), 7.88 (dd, J = 7.8 Hz, 1.5 Hz, 1H), 8.30 (d, J = 1.5 
Hz, 1H); 13C-NMR (CD3OD, 125 MHz): δ (ppm) 25.7, 26.4, 28.4, 29.1, 36.0, 66.8, 81.3, 
81.4, 81.9, 82.5, 104.4, 116.3, 122.8, 125.9, 131.9, 132.1, 132.4, 135.1, 135.5, 136.9, 
155.5, 158.9, 166.1, 174.7.  
Jiao, G.-S.; Thoresen, L. H.; Burgess, K. J. Am. Chem. Soc. 2003, 125, 14668-14669. 
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 5-Nitrofluorescein diacetate (32).  4-Nitrophthalic anhydride 30 (5 g, 25.5 
mmol) and 1,3-dihydroxybenzene 23 (5.6 g, 51 mmol) were dissolved in 75 mL of 
methanesulfonic acid.  After the reaction mixture was stirred at 85 oC for 72 h, the 
mixture was cooled to room temperature and then added in small portions to 425 mL of 
an ice water mixture.  The precipitate was collected by filtration and dried in the oven to 
give a mixture of 5- and 6-nitrofluorescein 31a and 31b.  The crude nitrofluorescein 
mixture was used further without any purification in the acylation reaction.  In the same 
manner as for 26, the 5-nitrofluorescein diacetate was isolated by repeated 
recrystallization from acetic anhydride to afford pure 32 (3.5 g, 30 %) as a light brown 
powder.  1H-NMR (DMSO-d6, 300 MHz): δ (ppm) 2.33 (s, 6H), 6.98-7.10 (m, 4H), 7.36 
(d, J = 2.1 Hz, 2H), 7.80 (d, J = 9 Hz, 1H), 8.64 (dd, J = 6.3 Hz, 4.2 Hz, 1H), 8.76 (d, J = 
9 Hz, 1H). 
Literature Data: 1H-NMR (DMSO-d6, 300 MHz): δ (ppm) 2.28 (s, 6H), 6.52 – 7.05 (m, 
4H), 7.30 (d, 2H), 7.75 (d, 1H), 8.55 (dd, 1H), 8.70 (d, 1H).  
Sigmund, H; Pfleiderer, W. Helv. Chim. Acta 2003, 86, 2299-2334. 
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 Sodium 5-nitro-2-carboxy-benzenesulfonate (34).  A mixture of 2-methyl-5-
nitrobenzenesulfonic acid 33 (25.0 g, 115 mmol) and NaOH (3.95 g, 98.9 mmol) was 
dissolved in 170 mL of water with heating.  Potassium permanganate (70.4 g, 445.43 
mmol in 250 mL of water) was added, and the reaction mixture was stirred with heating 
for 3 h.  The brown suspension was filtered through Celite and the filtrate was 
concentrated in vacuo to 100 mL.  The mixture was cooled to room temperature, and the 
crystals were collected by filtration and rinsed with H2O, EtOH, and then Et2O.  The 
mother liquor was concentrated to 50 mL and cooled to room temperature, then the 
crystals were collected by filtration.  The first and the second crops were combined and 
dissolved in 100 mL of water and 8 mL of concentrated HCl with warming.  Then 150 
mL of EtOH was added to the hot solution and it was then allowed to stand at room 
temperature overnight.  The crystals were collected by filtration and washed with cold 
50/50 EtOH/H2O, EtOH, and then Et2O to give 34 (20.4 g, 66 %) as white needles: 1H-
NMR (D2O, 300 MHz): δ (ppm) 7.36 (d, J = 8.5 Hz, 1H), 8.18 (dd, J = 3.6 Hz, 2.5 Hz, 
1H), 8.46 (d, J = 2.5 Hz, 1H); 13C-NMR (D2O, 75 MHz): δ (ppm) 122.86, 126.33, 
128.12, 139.29, 144.59, 146.52, 175.11. 
Conrow, R. B.; Bernstein, S., US Patent 4608205, 1986. 
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 Sodium 5-nitro-2-carboxy-benzenesulfonate (35).  Sodium 5-nitro-2-carboxy-
benzenesulfonate 34 (0.5 g, 1.85 mmol) was dissolved in H2O (5 mL) and Pd/C (10 %, 
0.19 g, 0.185 mmol) was then added.  The suspension was flushed with H2 and stirred at 
80 oC for 3 h.  The black suspension was then filtered through Celite and the filtrate was 
concentrated in vacuo to give 35 (0.35 g, 80 %) as a white solid: 1H-NMR (D2O, 300 
MHz): δ (ppm) 6.75 (dd, J = 5.5 Hz, 2.5 Hz, 1H), 7.00 (d, J = 8.5 Hz, 1H), 7.02 (d, J = 
2.5 Hz, 1H); 13C-NMR (D2O, 75 MHz): δ (ppm) 114.08, 118.73, 128.41, 130.28, 139.10, 
146.29, 177.88. 
Conrow, R. B.; Bernstein, S., US Patent 4608205, 1986. 
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 Sodium 2-carboxy-5-iodo-benzenesulfonate (36).  To a solution of sodium 5-
nitro-2-carboxy-benzenesulfonate 35 (0.50 g, 2.09 mmol) in 7 mL of 12 N HCl was 
added 3.6 g ice and the reaction mixture was cooled and stirred in an ice/water bath.  
Sodium nitrite (0.18 g, 2.6 mmol) in 3.5 mL was added dropwise over 2 min and the 
mixture was stirred at 0 oC for 30 min.  Potassium iodide (3.45 g, 20.8 mmol) in 6 mL of 
water was added dropwise over 2 min with vigorous stirring at 0 oC.  The cooling bath 
was removed and the reaction mixture was stirred for a further 1 h at room temperature.  
The mixture was extracted three times with 25 % iPrOH/CHCl3, then the combined 
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organic extracts were washed with saturated aqueous Na2S2O3 and dried over anhydrous 
Na2SO4.  The filtrate was evaporated in vacuo to afford the title compound 36 (0.47 g, 
65 %) as an off-white solid: 1H-NMR (D2O, 300 MHz): δ (ppm) 6.95 (dd, J = 2.6 Hz, 
5.7 Hz, 1H), 7.45 (d, J = 2.6 Hz, 1H), 7.82 (d, J = 8.5 Hz, 1H). 
Conrow, R. B.; Bernstein, S., US Patent 4608205, 1986. 
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 5-Iodo-2-sulfobenzoic anhydride (37).  A mixture of sodium 5-iodo-2-
sulfobenzoate 36 (1 g, 2.85 mmol) and thionyl chloride (2.1 mL, 28.57 mmol) was 
heated at reflux for 7 h.  The reaction mixture was then cooled to room temperature and 
thionyl chloride was distilled off.  To the remaining mixture was added 10 mL of 
benzene and the solution was boiled for 1 h.  The mixture was filtered while hot and the 
solid was washed with hot benzene (2 x 5 mL).  The filtrates were combined and the 
solution was concentrated in vacuo until 2 mL of solution remained.  The solution was 
then cooled in an ice bath, the crystals were collected by filtration, and the crude product 
was recrystallized from benzene to give 37 (0.26 g, 30 %) as an off-white solid: 1H-
NMR (CDCl3, 300 MHz): δ (ppm) 7.84 (dd, J = 8.1, 0.6 Hz, 1H), 8.29 (dd, J = 8.1 Hz, 
1.5 Hz, 1H), 8.36 (dd, J = 0.6 Hz, 1H); 13C-NMR (CDCl3, 75 MHz): δ (ppm) 105.2, 
124.3, 128.4, 131.3, 141.2, 144.4, 154.00; MS (ESI): m/z 311 (M+H)+. 
Literature Data: 1H-NMR (CDCl3, 300 MHz): δ (ppm) 7.84 (dd, J = 8.1 Hz, 0.5 Hz, 1H), 
8.30 (dd, J = 8.1 Hz, 1.2 Hz, 1H), 8.36 (dd, J = 1.2 Hz, 0.5 Hz, 1H); 13C-NMR (CDCl3, 
75 MHz): δ (ppm) 105.33, 124.70, 128.61, 131.44, 141.34, 144.77, 154.91; MS (ESI): 
m/z 311 (M+H)+. 
Jiao, G.-S.; Han, J. W.; Burgess, K. J. Org. Chem. 2003, 68, 8264-8267.  
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5-Iodosulfofluorescein (38).  5-Iodo-2-sulfobenzoic anhydride 37 (27.7 mg, 
0.09 mmol) and 1,3-dihydroxybenzene 23 (19.6 mg, 0.18 mmol) were dissolved in 0.2 
mL of methanesulfonic acid.  After the reaction mixture was stirred at 85 oC for 22 h, it 
was cooled to room temperature and then was poured into a minimum amount of water.  
The precipitated solid was collected by filtration, then dissolved in 10 % NaOH solution, 
and filtered again.  The filtrate was acidified with concentrated HCl.  A precipitate 
formed upon acidification and was collected by filtration, and dried in vacuo to afford 38 
(38 mg, 90 %) as a reddish solid: 1H-NMR (acetone-d6, 300 MHz): δ (ppm) 6.68 (d, J = 
7.8 Hz, 1H), 6.74 (dd, J = 8.8 Hz, 2.5 Hz, 2H), 6.79 (d, J = 2.5 Hz, 2H), 7.36 (d, J = 8.8 
Hz, 2H), 7.90 (dd, J = 7.8 Hz, 1.3 Hz, 1H), 8.10 (d, J = 1.3 Hz 1H). 
Literature Data: 1H-NMR (DMSO-d6, 300 MHz): δ (ppm) 7.11 (d, J = 7.9 Hz, 1H), 7.18 
(dd, J = 9.2 Hz, 2.2 Hz, 2H), 7.33 (d, J = 2.2 Hz, 2H), 7.44 (d, J = 9.2 Hz, 2H), 7.98 (dd, 
J = 7.9 Hz, 1.8 Hz, 1H), 8.21 (d, J = 1.8 Hz, 1H).    
Jiao, G.-S.; Han, J. W.; Burgess, K. J. Org. Chem. 2003, 68, 8264-8267. 
  
O40  
 
Acetyltetralin (40).  To a cooled solution of tetralin 39 (5 g, 37.82 mmol) and 
acetyl chloride (3.03 g, 38.6 mmol) in 23 mL of benzene was added anhydrous 
aluminum chloride (5.7 g, 42.7 mmol) in small portions over a period of 10 min, while 
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the temperature of the mixture was held below 10 oC.  The reaction mixture was stirred 
until the hydrogen chloride evolution ceased.  The mixture was then poured into ice, and 
acetyltetralin 40 (4.8 g, 80 %) was isolated by vacuum distillation as light yellow oil: 1H-
NMR (CDCl3, 300 MHz): δ (ppm) 1.82 (m, 4H), 2.58 (s, 3H), 2.81 (m, 4H), 7.15 (d, J = 
8.1 Hz, 1H), 7.67 - 7.70 (dd, J = 8.1 Hz, 2.7 Hz, 2H); 13C-NMR (CDCl3, 75 MHz): δ 
(ppm) 23.03, 23.23, 26.67, 29.59, 29.84, 125.63, 129.41, 129.51, 134.90, 137.52, 143.28, 
198.14. 
Literature Data: 1H-NMR (CDCl3, 400 MHz): δ (ppm) 1.79 – 1.84 (m, 4H), 2.57 (s, 3H), 
2.78 – 2.84 (m, 4H), 7.14 (d, J = 8.4 Hz, 1H), 7.64 – 7.69 (m, 2H); 13C-NMR (CDCl3, 
100 MHz): δ (ppm) 22.94, 23.08, 26.57, 29.47, 29.73, 125.27, 129.06, 129.15, 134.54, 
137.24, 143.00, 197.88.  
Kido, Y.; Yonehara, F.; Yamaguchi, H. Tetrahedron 2001, 57, 827-833. 
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 6-Acetyltetralin oxime (41).  To a solution of 40 (9.44 g, 54.18 mmol) in 
ethanol (50 mL) was added pyridine (13 mL, 162.5 mmol) and hydroxylamine 
hydrochloride (11.3 g, 162.5 mmol).  The reaction mixture was stirred at 60 oC for 1 h 
and then the solution was concentrated in vacuo.  The residue was then diluted with 
Et2O, washed with water (3 x mL), dried over anhydrous MgSO4, and the solvent was 
evaporated under reduced pressure.  The solid was further recrystallized from ethyl 
acetate to afford g of 41 (9.7 g, 95 %) as white crystals: 1H-NMR (CDCl3, 300 MHz): δ 
(ppm) 1.82 (m, 4H), 2.27 (s, 3H), 2.80 (m, 4H), 7.08 (d, J = 7.2 Hz, 1H), 7.33 (d, 7.2 Hz, 
1H), 7.38 (s, 1H); 13C-NMR (CDCl3, 75 MHz): δ (ppm) 12.60, 23.36, 23.39, 29.52, 
29.75, 123.42, 127.04, 129.55, 134.02, 137.52, 138.87, 156.37; MS (ESI): m/z 190 
(M+H)+. 
 73
Brown, A. T.; Hallas G.; Lawson, R. Chem. Ind. 1981, 248-249. 
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6-Acetamidotetralin (42).  To a solution of 41 (5 g, 26.4 mmol) in 50 mL of 
pyridine was slowly added 6 mL of benzenesulphonyl chloride.  The reaction mixture 
was stirred for 3 hours and the temperature was kept below 15 oC.  The solution was 
then poured into a mixture of ice and 1M hydrochloric acid (~ 100 mL).  After several 
hours, 6-acetamidotetralin separated, was washed with water, and filtered to yield of 6-
acetamidotetralin 42 (3.0 g, 60 %) as a white solid: 1H-NMR (acetone-d6), 300 MHz): δ 
(ppm) 1.80 (m, 4H), 2.08 (s, 3H), 2.72 (m, 4H), 7.00 (d, J = 8.2 Hz, 1H), 7.34 (d, J = 8.2 
Hz, 1H), 7.38 (s, 1H), 9.00 (1H, s, NH); 13C-NMR (DMSO-d6, 75 MHz): δ (ppm) 23.46, 
23.58, 24.64, 28.93, 29.70, 117.42, 119.93, 129.60, 131.82, 137.20, 137.49, 168.7; MS 
(ESI): m/z 190 (M+H)+. 
Literature Data: 1H-NMR (CDCl3): δ (ppm) 1.66 – 2.00 (m, 4H), 2.16 (s, 3H), 2.60 – 
2.90 (m, 4H), 7.00 (d, J = 8 Hz, 1H), 7.23 (d, J = 8 Hz, 1H), 7.30 (s, 1H), 8.00 (1H, s, 
NH). 
Daly, C. M..; Iddon, B; Suschitzky, H. J. Chem. Soc. Perkin Trans I  1988, 7, 1933-
1938. 
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6-Acetamidotetralone (43).  To a solution of 6-acetamidotetralin 42 (2 g, 10.5 
mmol) in 4.8 mL of acetic acid and 1.4 mL of acetic anhydride was added a solution of 
chromium trioxide (1.38 g, 13.8 mmol) in 1 mL of water and 4 mL of acetic acid, while 
the temperature of the reaction mixture was kept below 10 oC by external cooling.  After 
the solution was stirred overnight, it was poured into 70 mL of ice-water mixture and 
filtered.  The crude product was adsorbed onto silica, then purified by flash 
chromatography eluting with 40%  EtOAc/Hexanes to afford 43 (0.9 g, 40 %) as a pale 
yellow solid: 1H-NMR (CD3OD, 300 MHz): δ (ppm) 2.12 (m, 2H), 2.17 (s, 3H), 2.64 (t, 
J = 6.0 Hz, 2H), 2.95 (t, J = 6.3 Hz, 2H), 7.48 (d, J = 8.7 Hz, 1H), 7.66 (s, 1H), 7.94 (d, J 
= 8.7 Hz, 1H); 13C-NMR (acetone-d6, 75 MHz): δ (ppm) 23.50, 23.80, 28.50, 38.80, 
117.20, 118.00, 128.10, 128.20, 144.10, 142.5, 168.80, 196.00; MS (ESI): m/z 204 
(M+H)+. 
Allinger, N. L.; Jones, E. S. J. Org. Chem. 1962, 27, 70-76. 
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6-Acetamido-2-benzylidene-1-tetralone (45).  6-Acetamidotetralone 43 (0.5 
mg, 2.45 mmol) and 4-bromobenzaldehyde (0.45 g, 2.45 mmol) were treated with 3 mL 
of 4 % ethanolic potassium hydroxide at 25 oC.  The crystals were deposited almost 
immediately.  After 2 hours, the solution was neutralized with acetic acid, water was 
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added, and the crystals were filtered.  The crude product was then recrystallized from 
ethanol to give 45 (0.7 g, 85 %) as orange crystals: 1H-NMR (acetone-d6, 300 MHz): δ 
(ppm) 2.09 (s, 3H), 2.98 (t, J = 6.3 Hz, 2H), 3.12 (t, J = 6.3 Hz, 2H), 7.50 - 7.70 (m,7H), 
7.81 (s, 1H), 8.05 (dd, J = 6 Hz, 2.6 Hz, 1H);  
13C-NMR (CDCl3, 75 MHz): δ (ppm) 25.13, 27.39, 29.29, 117.97, 118.24, 122.96, 
129.70, 129.98, 131.61 (2 CH), 131.94 (2 CH), 134.96, 135.41, 136.25, 142.61, 145.29, 
168.90, 186.90; MS (ESI): m/z 370/372 (M+H)+. 
 
O
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46  
 
Diamonopyrylium salt (46).  6-Acetamido-2-benzylidene-1-tetralone 45 (0.8 g, 
2.16 mmol) and 6-acetamidotetralone 43 (0.41 g, 2.02 mmol) were heated at 100 oC with 
4 mL of boron trifluoride-ether with stirring for 24 hours. The reaction mixture was then 
cooled to room temperature and then stirred with Et2O.  The product was filtered and 
washed with Et2O to give 1.3 g of diaminopyrylium tetrafluoroborate was obtained.  To 
a solution of crude product in CH2Cl2/H2O was added sodium tetra(3,5-
trifluoromethylbenzene)boronate (NaBARF) (4.1 g, 4.6 mmol).  The mixture was stirred 
at room temperature for 12 hours.  The mixture was then extracted with 25 % 
isopropanol in chloroform, and the organic extract was washed with H2O.  The organic 
layer was dried over anhydrous Na2SO4 and evaporated under reduced pressure.  The 
crude product was adsorbed on silica, then purified by flash chromatography eluting 
with 50 % EtOAc/Hexanes, but 46 could not be isolated because of the unavailability of 
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HPLC to purify it, so that the 1H-NMR and 13C-NMR taken were messy; mp not taken 
because the compound was impure; MS (ESI): m/z 469/471 M+. 
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2-Benzylidene-1-tetralone (48).  In the same manner as for 45, the title 
compound was prepared by using tetralone 47 (3.7 g, 25.3 mmol), 4-bromo-
benzaldehyde (4.7 g, 25.3 mmol), and 3 mL of 4 % ethanolic potassium hydroxide.  The 
crude product was then recrystallized from ethanol to give 48 (6.3 g, 80 %) as orange 
crystals: 1H-NMR (CDCl3, 300 MHz): δ (ppm) 2.98 (t, J = 6.9 Hz, 2H), 3.12 (t, J = 6.9 
Hz, 2H), 7.30-7.60 (m,7H), 7.81 (s, 1H), 8.16 (dd, J = 6.3 Hz, 1.5 Hz, 1H); 13C-NMR 
(CDCl3, 75 MHz): δ (ppm) 27.45, 29.03, 122.99, 127.38, 128.48, 128.53, 131.63 (2 CH), 
131.94 (2 CH), 133.59, 133.69, 134.97, 135.55, 136.33, 143.41, 187.92. 
Hammam, A. E.; Hussain, M.; Kotob, I. R. Phosphorus, Sulfur, and Silicon 1990, 47, 
47-51.       
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49  
 
Monoaminopyrylium salt (48).  In the same manner as for 46, the title 
compound was prepared by using 2-benzylidene-1-tetralone 48 (0.81 g 2.58 mmol), 6-
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acetamidotetralone 43 (0.5 g, 2.46 mmol), boron trifluoride-ether (5 mL, 40 mmol), and 
NaBARF (4.9 g, 5.54 mmol) to give 1.5 g of monoaminopyrylium tetrafluoroborate.  
The crude product was adsorbed on silica, then purified by flash chromatography eluting 
with, but 49 could not be isolated either because of the unavailability of HPLC to purify 
it, so that the 1H-NMR taken was messy; mp not taken because the compound was 
impure; MS (ESI): m/z 454/456 M+. 
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